@phdthesis{Alkhargi2020, author = {Alkhargi, Manuel}, title = {Cancer And Living Meaningfully: eine qualitative Studie zur Treatment Integrity der CALM-Therapie im Vergleich zu einer Kontrollbedingung}, doi = {10.25972/OPUS-19939}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-199390}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2020}, abstract = {Hintergrund: Circa ein Drittel der Patientinnen und Patienten mit fortgeschrittenen Krebserkrankungen ist von psychischen Komorbidit{\"a}ten betroffen und circa die H{\"a}lfte weist eine psychische Belastung im klinisch signifikanten Bereich auf. Zur psychotherapeutischen Behandlung dieser Patientengruppe stehen unterschiedliche psychotherapeutische Interventionen zur Verf{\"u}gung. Die CALM-Therapie, eine manualisierte Kurzintervention im Einzelsetting, ist eine dieser Interventionen. Hier bilden vier Module, welche auf den wichtigsten Anliegen und Belastungsfaktoren von Patientinnen und Patienten mit fortgeschrittenen Krebserkrankungen basieren, den inhaltlichen Rahmen. Ziel: Die Treatment Integrity beschreibt das Maß, inwieweit eine psychotherapeutische Intervention wie vorgesehen umgesetzt wurde. F{\"u}r eine fundierte Interpretation psychotherapeutischer Interventionseffekte sind Kenntnisse {\"u}ber die Treatment Integrity entscheidend. Die vorliegende Arbeit untersuchte Teilaspekte der Treatment Integrity durchgef{\"u}hrter CALM-Therapien im Vergleich zu durchgef{\"u}hrten konventionellen psychoonkologischen Therapien, um einen Beitrag zu einer fundierten Interpretation von Interventionseffekten der CALM-Therapie zu leisten. Methoden: Transkriptionen von zwei CALM-Therapien und zwei Therapien einer konventionellen psychoonkologischen Intervention wurden anhand einer qualitativen Inhaltsanalyse nach P. Mayring untersucht. Im Zentrum stand hierbei ein selbst entwickeltes Kategoriensystem zur Analyse des gesamten Textmaterials. Zus{\"a}tzlich wurden Auff{\"a}lligkeiten bez{\"u}glich Ansprachen von Themenbereichen der CALM-Module unsystematisch beobachtet. Ergebnisse: Die Inhalte der untersuchten CALM-Therapien bezogen sich durchschnittlich zu 99,54\% und die der konventionellen psychoonkologischen Therapien durchschnittlich zu 98,71\% auf die Themenbereiche der CALM-Module. Die ermittelten Werte f{\"u}r einzelne Therapiesitzungen lagen f{\"u}r CALM-Sitzungen zwischen 98,12\% und 100\% und f{\"u}r Sitzungen der konventionellen psychoonkologischen Therapie zwischen 96,20\% und 100\%. Unsystematisch beobachtete Auff{\"a}lligkeiten zeigten, dass die Themenbereiche der CALM-Module zum Teil sehr spezifisch durch die CALM-Therapeutinnen und -Therapeuten angesprochen und vernetzt wurden. Schlussfolgerung: Unter Ber{\"u}cksichtigung von methodischen Grenzen zeigte sich bez{\"u}glich des Anteils von Themenbereichen der CALM-Module innerhalb der beiden untersuchten Therapiegruppen kein maßgeblicher Unterschied. Zus{\"a}tzlich liefert die vorliegende Arbeit Hinweise f{\"u}r einen spezifischen therapeutischen Umgang mit den Themenbereichen der CALM-Module innerhalb der untersuchten CALM-Therapien. Um ermittelte Interventionseffekte der CALM-Therapie fundiert interpretieren zu k{\"o}nnen, sollten zuk{\"u}nftige Untersuchungen unterschiedliche Umgangsweisen von Therapeutinnen und Therapeuten der beiden Therapiegruppen mit den Themenbereichen der CALM-Module genauer in den Blick nehmen.}, subject = {Psychoonkologie}, language = {de} } @article{KraftDrechslerGunrebenetal.2014, author = {Kraft, Peter and Drechsler, Christiane and Gunreben, Ignaz and Heuschmann, Peter Ulrich and Kleinschnitz, Christoph}, title = {Regulation of Blood Coagulation Factors XI and XII in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study}, series = {Cerebrovascular Diseases}, volume = {38}, journal = {Cerebrovascular Diseases}, number = {5}, issn = {1015-9770}, doi = {10.1159/000368434}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-199076}, pages = {337-343}, year = {2014}, abstract = {Background: Animal models have implicated an integral role for coagulation factors XI (FXI) and XII (FXII) in thrombus formation and propagation of ischemic stroke (IS). However, it is unknown if these molecules contribute to IS pathophysiology in humans, and might be of use as biomarkers for IS risk and severity. This study aimed to identify predictors of altered FXI and FXII levels and to determine whether there are differences in the levels of these coagulation factors between acute cerebrovascular events and chronic cerebrovascular disease (CCD). Methods: In this case-control study, 116 patients with acute ischemic stroke (AIS) or transitory ischemic attack (TIA), 117 patients with CCD, and 104 healthy volunteers (HVs) were enrolled between 2010 and 2013 at our University hospital. Blood sampling was undertaken once in the CCD and HV groups and on days 0, 1, and 3 after stroke onset in patients with AIS or TIA. Correlations between serum FXI and FXII levels and demographic and clinical parameters were tested by linear regression and analysis of variance. Results: The mean age of AIS/TIA patients was 70 ± 12. Baseline clinical severity measured with NIHSS and Barthel Index was 4.8 ± 6.0 and 74 ± 30, respectively. More than half of the patients had an AIS (58\%). FXI levels were significantly correlated with different leukocyte subsets (p < 0.05). In contrast, FXII serum levels showed no significant correlation (p > 0.1). Neither FXI nor FXII levels correlated with CRP (p > 0.2). FXII levels were significantly higher in patients with CCD compared with those with AIS/TIA (mean ± SD 106 ± 26\% vs. 97 ± 24\%; univariate analysis: p < 0.05); these differences did not reach significance in multivariate analysis adjusted for sex and age. FXI levels did not differ significantly between study groups. Sex and age were significantly associated with FXI and/or FXII levels in patients with AIS/TIA (p < 0.05). In contrast, no statistical significant influence was found for treatment modality (thrombolysis or not), pre-treatment with platelet inhibitors, and severity of stroke. Conclusions: In this study, there was no differential regulation of FXI and FXII levels between disease subtypes but biomarker levels were associated with patient and clinical characteristics. FXI and FXII levels might be no valid biomarker for predicting stroke risk.}, language = {en} } @article{KotsevaDeBackerDeBacqueretal.2019, author = {Kotseva, Kornelia and De Backer, Guy and De Bacquer, Dirk and Ryd{\´e}n, Lars and Hoes, Arno and Grobbee, Diederick and Maggioni, Aldo and Marques-Vidal, Pedro and Jennings, Catriona and Abreu, Ana and Aguiar, Carlos and Badariene, Jolita and Bruthans, Jan and Castro Conde, Almudena and Cifkova, Renata and Crowley, Jim and Davletov, Kairat and Deckers, Jaap and De Smedt, Delphine and De Sutter, Johan and Dilic, Mirza and Dolzhenko, Marina and Dzerve, Vilnis and Erglis, Andrejs and Fras, Zlatko and Gaita, Dan and Gotcheva, Nina and Heuschmann, Peter and Hasan-Ali, Hosam and Jankowski, Piotr and Lalic, Nebojsa and Lehto, Seppo and Lovic, Dragan and Mancas, Silvia and Mellbin, Linda and Milicic, Davor and Mirrakhimov, Erkin and Oganov, Rafael and Pogosova, Nana and Reiner, Zeljko and St{\"o}erk, Stefan and Tokg{\"o}zoğlu, L{\^a}le and Tsioufis, Costas and Vulic, Dusko and Wood, David}, title = {Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry}, series = {European Journal of Preventive Cardiology}, volume = {26}, journal = {European Journal of Preventive Cardiology}, number = {8}, organization = {EUROASPIRE Investigators}, issn = {2047-4873}, doi = {10.1177/2047487318825350}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-205526}, pages = {824-835}, year = {2019}, abstract = {Aims The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results A total of 8261 patients (females 26\%) were interviewed. Nineteen per cent smoked and 55\% of them were persistent smokers, 38\% were obese (body mass index ≥30 kg/m2), 59\% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66\% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71\% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29\% reported having diabetes. Cardioprotective medication was: anti-platelets 93\%, beta-blockers 81\%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75\% and statins 80\%. Conclusion A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.}, language = {en} } @article{DenglerMaldanerGlaeskeretal.2016, author = {Dengler, Julius and Maldaner, Nicolai and Gl{\"a}sker, Sven and Endres, Matthias and Wagner, Martin and Malzahn, Uwe and Heuschmann, Peter U. and Vajkoczy, Peter}, title = {Outcome of Surgical or Endovascular Treatment of Giant Intracranial Aneurysms, with Emphasis on Age, Aneurysm Location, and Unruptured Aneuryms - A Systematic Review and Meta-Analysis}, series = {Cerebrovascular Diseases}, volume = {41}, journal = {Cerebrovascular Diseases}, number = {3-4}, organization = {Giant Intracranial Aneurysm Study Group}, issn = {1015-9770}, doi = {10.1159/000443485}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-196792}, pages = {187-198}, year = {2016}, abstract = {Background: Designing treatment strategies for unruptured giant intracranial aneurysms (GIA) is difficult as evidence of large clinical trials is lacking. We examined the outcome following surgical or endovascular GIA treatment focusing on patient age, GIA location and unruptured GIA. Methods: Medline and Embase were searched for studies reporting on GIA treatment outcome published after January 2000. We calculated the proportion of good outcome (PGO) for all included GIA and for unruptured GIA by meta-analysis using a random effects model. Results: We included 54 studies containing 64 study populations with 1,269 GIA at a median follow-up time (FU-T) of 26.4 months (95\% CI 10.8-42.0). PGO was 80.9\% (77.4-84.4) in the analysis of all GIA compared to 81.2\% (75.3-86.1) in the separate analysis of unruptured GIA. For each year added to patient age, PGO decreased by 0.8\%, both for all GIA and unruptured GIA. For all GIA, surgical treatment resulted in a PGO of 80.3\% (95\% CI 76.0-84.6) compared to 84.2\% (78.5-89.8, p = 0.27) after endovascular treatment. In unruptured GIA, PGO was 79.7\% (95\% CI 71.5-87.8) after surgical treatment and 84.9\% (79.1-90.7, p = 0.54) after endovascular treatment. PGO was lower in high quality studies and in studies presenting aggregate instead of individual patient data. In unruptured GIA, the OR for good treatment outcome was 5.2 (95\% CI 2.0-13.0) at the internal carotid artery compared to 0.1 (0.1-0.3, p < 0.1) in the posterior circulation. Patient sex, FU-T and prevalence of ruptured GIA were not associated with PGO. Conclusions: We found that the chances of good outcome after surgical or endovascular GIA treatment mainly depend on patient age and aneurysm location rather than on the type of treatment conducted. Our analysis may inform future research on GIA.}, language = {en} } @article{KolominskyRabasWiedmannWeingaertneretal.2015, author = {Kolominsky-Rabas, Peter L. and Wiedmann, Silke and Weing{\"a}rtner, Michael and Liman, Thomas G. and Endres, Matthias and Schwab, Stefan and Buchfelder, Michael and Heuschmann, Peter U.}, title = {Time Trends in Incidence of Pathological and Etiological Stroke Subtypes during 16 Years: The Erlangen Stroke Project}, series = {Neuroepidemiology}, volume = {44}, journal = {Neuroepidemiology}, number = {1}, issn = {0251-5350}, doi = {10.1159/000371353}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-196503}, pages = {24-29}, year = {2015}, abstract = {Background: Population-based data, which continuously monitors time trends in stroke epidemiology are limited. We investigated the incidence of pathological and etiological stroke subtypes over a 16 year time period. Methods: Data were collected within the Erlangen Stroke Project (ESPro), a prospective, population-based stroke register in Germany covering a total study population of 105,164 inhabitants (2010). Etiology of ischemic stroke was classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Results: Between January 1995 and December 2010, 3,243 patients with first-ever stroke were documented. The median age was 75 and 55\% were females. The total stroke incidence decreased over the 16 year study period in men (Incidence Rate Ratio 1995-1996 vs. 2009-2010 (IRR) 0.78; 95\% CI 0.58-0.90) but not in women. Among stroke subtypes, a decrease in ischemic stroke incidence (IRR 0.73; 95\% CI 0.57-0.93) and of large artery atherosclerotic stroke (IRR 0.27; 95\% CI 0.12-0.59) was found in men and an increase of stroke due to small artery occlusion in women (IRR 2.33; 95\% CI 1.39-3.90). Conclusions: Variations in time trends of pathological and etiological stroke subtypes were found between men and women that might be linked to gender differences in the development of major vascular risk factors in the study population.}, language = {en} } @article{SchneiderGutjahrLengsfeldRitzetal.2014, author = {Schneider, Andreas and Gutjahr-Lengsfeld, Lena and Ritz, Eberhard and Scharnagl, Hubert and Gelbrich, G{\"o}tz and Pilz, Stefan and Macdougall, Iain C. and Wanner, Christoph and Drechsler, Christiane}, title = {Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients}, series = {Nephron Clinical Practice}, volume = {128}, journal = {Nephron Clinical Practice}, number = {1-2}, issn = {1660-2110}, doi = {10.1159/000367975}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-196511}, pages = {147-152}, year = {2014}, abstract = {Background: Dose requirements of erythropoietin-stimulating agents (ESAs) can vary considerably over time and may be associated with cardiovascular outcomes. We aimed to longitudinally assess ESA responsiveness over time and to investigate its association with specific clinical end points in a time-dependent approach. Methods: The German Diabetes and Dialysis study (4D study) included 1,255 diabetic dialysis patients, of whom 1,161 were receiving ESA treatment. In those patients, the erythropoietin resistance index (ERI) was assessed every 6 months during a median follow-up of 4 years. The association between the ERI and cardiovascular end points was analyzed by time-dependent Cox regression analyses with repeated ERI measures. Results: Patients had a mean age of 66 ± 8.2 years; 53\% were male. During follow-up, a total of 495 patients died, of whom 136 died of sudden death and 102 of infectious death. The adjusted and time-dependent risk for sudden death was increased by 19\% per 5-unit increase in the ERI (hazard ratio, HR = 1.19, 95\% confidence interval, CI = 1.07-1.33). Similarly, mortality increased by 25\% (HR = 1.25, 95\% CI = 1.18-1.32) and infectious death increased by 27\% (HR = 1.27, 95\% CI = 1.13-1.42). Further analysis revealed that lower 25-hydroxyvitamin D levels were associated with lower ESA responsiveness (p = 0.046). Conclusions: In diabetic dialysis patients, we observed that time-varying erythropoietin resistance is associated with sudden death, infectious complications and all-cause mortality. Low 25-hydroxyvitamin D levels may contribute to a lower ESA responsiveness.}, language = {en} } @article{HohmannPinartTischeretal.2014, author = {Hohmann, Cynthia and Pinart, Mariona and Tischer, Christina and Gehring, Ulrike and Heinrich, Joachim and Kull, Inger and Mel{\´e}n, Eric and Smit, Henriette A. and Torrent, Maties and Wijga, Alet H. and Wickman, Magnus and Bachert, Claus and L{\o}drup Carlsen, Karin C. and Carlsen, Kai-H{\aa}kon and Bindslev-Jensen, Carsten and Eller, Esben and Esplugues, Ana and Fantini, Maria Pia and Annesi-Maesano, Isabella and Momas, Isabelle and Porta, Daniela and Vassilaki, Maria and Waiblinger, Dagmar and Sunyer, Jordi and Ant{\´o}, Josep M. and Bousquet, Jean and Keil, Thomas}, title = {The Development of the MeDALL Core Questionnaires for a Harmonized Follow-Up Assessment of Eleven European Birth Cohorts on Asthma and Allergies}, series = {International Archives of Allergy and Immunology}, volume = {163}, journal = {International Archives of Allergy and Immunology}, number = {3}, organization = {The MeDALL Study Group}, issn = {1018-2438}, doi = {10.1159/000357732}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-196594}, pages = {215-224}, year = {2014}, abstract = {Background: Numerous birth cohorts have been initiated in the world over the past 30 years using heterogeneous methods to assess the incidence, course and risk factors of asthma and allergies. The aim of the present work is to provide the stepwise proceedings of the development and current version of the harmonized MeDALL-Core Questionnaire (MeDALL-CQ) used prospectively in 11 European birth cohorts. Methods: The harmonization of questions was accomplished in 4 steps: (i) collection of variables from 14 birth cohorts, (ii) consensus on questionnaire items, (iii) translation and back-translation of the harmonized English MeDALL-CQ into 8 other languages and (iv) implementation of the harmonized follow-up. Results: Three harmonized MeDALL-CQs (2 for parents of children aged 4-9 and 14-18, 1 for adolescents aged 14-18) were developed and used for a harmonized follow-up assessment of 11 European birth cohorts on asthma and allergies with over 13,000 children. Conclusions: The harmonized MeDALL follow-up produced more comparable data across different cohorts and countries in Europe and will offer the possibility to verify results of former cohort analyses. Thus, MeDALL can become the starting point to stringently plan, conduct and support future common asthma and allergy research initiatives in Europe.}, language = {en} } @article{SchulerMurauerStangletal.2019, author = {Schuler, Michael and Murauer, Kathrin and Stangl, Stephanie and Grau, Anna and Gabriel, Katharina and Podger, Lauren and Heuschmann, Peter U. and Faller, Hermann}, title = {Pre-post changes in main outcomes of medical rehabilitation in Germany: protocol of a systematic review and meta-analysis of individual participant and aggregated data}, series = {BMJ Open}, volume = {9}, journal = {BMJ Open}, number = {5}, doi = {10.1136/bmjopen-2018-023826}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-201929}, pages = {e023826}, year = {2019}, abstract = {Introduction Multidisciplinary, complex rehabilitation interventions are an important part of the treatment of chronic diseases. However, little is known about the effectiveness of routine rehabilitation interventions within the German healthcare system. Due to the nature of the social insurance system in Germany, randomised controlled trials examining the effects of rehabilitation interventions are challenging to implement and scarcely accessible. Consequently, alternative pre-post designs can be employed to assess pre-post effects of medical rehabilitation programmes. We present a protocol of systematic review and meta-analysis methods to assess the pre-post effects of rehabilitation interventions in Germany. Methods and analysis The respective study will be conducted within the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. A systematic literature review will be conducted to identify studies reporting the pre-post effects (start of intervention vs end of intervention or later) in German healthcare. Studies investigating the following disease groups will be included: orthopaedics, rheumatology, oncology, pulmonology, cardiology, endocrinology, gastroenterology and psychosomatics. The primary outcomes of interest are physical/mental quality of life, physical functioning and social participation for all disease groups as well as pain (orthopaedic and rheumatologic patients only), blood pressure (cardiac patients only), asthma control (patients with asthma only), dyspnoea (patients with chronic obstructive pulmonary disease only) and depression/anxiety (psychosomatic patients only). We will invite the principal investigators of the identified studies to provide additional individual patient data. We aim to perform the meta-analyses using individual patient data as well as aggregate data. We will examine the effects of both study-level and patient-level moderators by using a meta-regression method. Ethics and dissemination Only studies that have received institutional approval from an ethics committee and present anonymised individual patient data will be included in the meta-analysis. The results will be presented in a peer-reviewed publication and at research conferences. A declaration of no objection by the ethics committee of the University of W{\"u}rzburg is available (number 20180411 01).}, language = {en} } @phdthesis{Scholz2017, author = {Scholz, Franca}, title = {Einfluss verschiedener Untersuchungsbedingugen auf die Messwerte der bioelektrischen Impedanzanalyse (EULE)}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-156032}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2017}, abstract = {HINTERGRUND. In zahlreichen epidemiologischen Studien, so auch in der bev{\"o}lkerungsbasierten W{\"u}rzburger Kohortenstudie STAAB (STAdien A und B der Herzinsuffizienz) mit prim{\"a}ren kardiologischen Fragestellungen, wird die K{\"o}rperzusammensetzung mittels bioelektrischer Impedanzanalyse (BIA) gemessen. In einer Pilotstudie wurden das Messprotokoll und die Reproduzierbarkeit der Messungen {\"u}berpr{\"u}ft. Außerdem wurde untersucht, wie sich die Verletzung bestimmter Protokollvorschriften (Messung am n{\"u}chternen Probanden im Ruhezustand) verzerrend auf die Messwerte auswirken. METHODEN. Die Probanden (16 M{\"a}nner, 18 Frauen) waren vollj{\"a}hrig, hatten keine mit dem Protokoll unvertr{\"a}glichen Erkrankungen oder Medikationen und erteilten ihre schriftliche informierte Einwilligung. In sechs konsekutiven BIA-Messungen wurden mittels Seca® mBCA 515 fettfreie Masse, Muskelmasse, Fettmasse, Fettanteil, Gesamtk{\"o}rperwasser und extrazellul{\"a}res Wasser unter verschiedenen Bedingungen bestimmt. Zun{\"a}chst wurden unter den vorgeschriebenen Standardbedingungen zwei direkt aufeinander folgende Messungen durchgef{\"u}hrt, zwischen denen die Probanden das Ger{\"a}t verließen. Die dritte Messung erfolgte unmittelbar nach dem Trinken von 500mL Mineralwasser, die vierte nach 20-30min Wartezeit. Anschließend unterzogen sich die Probanden unterzogen einer k{\"o}rperlichen Belastung (Laufen im Stand, Springen, Kniebeugen) bis zum Einsetzen einer deutlichen Schweißproduktion. Die f{\"u}nfte BIA-Messung erfolgte im unmittelbaren Anschluss an die Belastung, die sechste nach weiteren 5min Ruhepause. ERGEBNISSE. Die beiden unter Standardbedingungen durchgef{\"u}hrten Messungen lieferten bei den Probanden jeweils fast identische Werte. Die Wasseraufnahme wurde vom Ger{\"a}t bei M{\"a}nnern nur marginal (+100g), bei Frauen gar nicht als solche registriert. Vielmehr wurde eine signifikante Zunahme der Fettmasse angezeigt (M{\"a}nner +300g, Frauen +500g, siehe Abbildung). Die Fehlzuordnung des aufgenommenen Wassers verschob sich nach der Wartezeit nur geringf{\"u}gig. Nach der k{\"o}rperlichen Belastung wurde bei den M{\"a}nnern eine gestiegene Fettmasse gemessen (+400g, siehe Abbildung), die sich nach der kurzen Ruhepause wieder reduzierte (-300g), w{\"a}hrend sich die angezeigte K{\"o}rperwassermasse genau gegenl{\"a}ufig verhielt. Bei den Frauen waren die Ver{\"a}nderungen unter Belastung und nach der Ruhepause geringf{\"u}gig. Die Verlaufsprofile der Geschlechter unterschieden sich in allen Messvariablen signifikant (Interaktionstest). SCHLUSSFOLGERUNG. Die Messwerte des BIA-Ger{\"a}ts sind unter den definierten Standardbedingungen gut reproduzierbar. Die experimentellen Ver{\"a}nderungen der Protokollstandards simulierten allt{\"a}glich vorkommende Einflussfaktoren wie Wasserzufuhr oder k{\"o}rperliche Belastung kurz vor der Untersuchung. Die Ergebnisse zeigen, dass die Nichteinhaltung der Standards zu messbaren Verzerrungen f{\"u}hren. Dies ist umso gravierender, da die Verzerrungen in den vom Ger{\"a}t angezeigten Messwerten physikalisch nicht ihren kausalen Ursachen entsprechen und zudem bei den Geschlechtern verschieden ausgepr{\"a}gt sind. Vor dem Hintergrund dieser Ergebnisse sollten bei der epidemiologischen Interpretation statistischer Zusammenh{\"a}nge von BIA-Werten mit anderen Messgr{\"o}ßen auch immer die m{\"o}glichen Auswirkungen fehlerhafter Zuordnung von K{\"o}rperanteilen kritisch gepr{\"u}ft und er{\"o}rtert werden.}, subject = {Impedanzmessung}, language = {de} } @phdthesis{Lundt2018, author = {Lundt, Anna}, title = {Angst, Depressivit{\"a}t und Fatigue bei Tumorpatienten sechs Monate nach Beendigung einer Yogaintervention}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-166019}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2018}, abstract = {Onkologische Patienten sowie klinische Forscher zeigen zunehmendes Interesse an Yogainterventionen als komplement{\"a}res Therapieverfahren zur Behandlung psychischer und k{\"o}rperlicher Beschwerden. Kurzzeitige Effekte von Yogatherapien auf die h{\"a}ufig krebsassoziierten Symptome Angst, Depressivit{\"a}t und Fatigue wurden in zahlreichen Studien untersucht. Die Ergebnisse der Untersuchungen legen nahe, dass Tumorpatienten unmittelbar nach einer Yogaintervention eine Verbesserung der genannten Symptome erleben. Allerdings ist bisher unzureichend untersucht, ob ein R{\"u}ckgang von Angst, Depressivit{\"a}t und Fatigue langfristig besteht. Ziel der Studie war es daher, nachhaltige Ver{\"a}nderungen von Angst, Depressivit{\"a}t und Fatigue bei Tumorpatienten im Rahmen einer achtw{\"o}chigen Yogaintervention zu untersuchen. Wir nahmen an, dass Angst, Depressivit{\"a}t und Fatigue sechs Monate nach einer Yogaintervention genauso niedrig wie unmittelbar nach der Intervention sind und sich signifikant von den Ausgangswerten vor der Intervention unterscheiden. Außerdem sollte untersucht werden, wie viele Teilnehmer die Yogapraxis nach einer Yogaintervention fortf{\"u}hren und ob sich dies auf die Zielparameter auswirkt. Durch eine klinische Studie im Pr{\"a}-Post-Design wurden die Hypothesen gepr{\"u}ft. Dazu wurden Daten von 58 Teilnehmern mit unterschiedlichen Tumorerkrankungen vor, unmittelbar nach und sechs Monate nach einer achtw{\"o}chigen Gentle Hatha- Yogaintervention mittels standardisierter psychologischer Frageb{\"o}gen gesammelt. Die Mehrheit der Studienteilnehmer war weiblich (90\%) und wies anamnestisch eine Mammakarzinom-Erkrankung auf (55\%). Die Ergebnisse legen nahe, dass Angst und Fatigue zwischen Interventionsende und sechs Monaten sp{\"a}ter leicht zunahmen, wohingegen depressive Symptome stabil blieben. Im Vergleich zu den Ausgangswerten vor der Intervention waren Angst, Depressivit{\"a}t und Fatigue sechs Monate nach Interventionsende signifikant reduziert. Ein halbes Jahr nach Beendigung der Yogaintervention gaben 69\% der Teilnehmer an, weiterhin Yoga zu praktizieren. Befragungen zeigten, dass die Teilnehmer subjektiv von der Yogapraxis profitierten. Die fortgef{\"u}hrte Yogapraxis stand jedoch nicht mit der Auspr{\"a}gung von Angst, Depressivit{\"a}t und Fatigue zum Follow-up-Zeitpunkt in Zusammenhang. Die Ergebnisse deuten darauf hin, dass Tumorpatienten langfristig von einer Verbesserung von Angst, Depressivit{\"a}t und Fatigue im Rahmen einer Yogatherapie profitieren k{\"o}nnten. Ein kausaler Zusammenhang zwischen Yogatherapie und der gefundenen Verbesserung sechs Monate nach Therapieende konnte jedoch durch die fehlende Kontrollbedingung nicht belegt werden. In Zukunft sollten große randomisierte kontrollierte Studien die vermutete Kausalit{\"a}t untersuchen.}, subject = {Depression}, language = {de} } @phdthesis{Schich2017, author = {Schich, Martin Friedemann}, title = {Chronische Niereninsuffizienz und akutes Nierenversagen bei Patienten mit koronarer Herzerkrankung - Pr{\"a}valenz und Wahrnehmung von Arzt und Patient}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-143265}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2017}, abstract = {Die chronische Niereninsuffizienz (CKD) ist ein weltweites Gesundheitsproblem. Insbesondere in den Industrienationen stellt es aufgrund des demographischen Wandels eine große gesundheitliche und finanzielle Herausforderung dar, da besonders {\"a}ltere Menschen an einer eingeschr{\"a}nkten Nierenfunktion leiden. Hypertonie und Diabetes mellitus sind wichtige Risikofaktoren sowohl f{\"u}r die Entstehung der CKD, als auch f{\"u}r die koronare Herzerkrankung (KHK). Die Wahrnehmung der CKD in der Bev{\"o}lkerung ist niedrig, wodurch eine fr{\"u}hzeitige Diagnose erschwert wird. Die EUROASPIRE IV Studie hat es erm{\"o}glicht, die Pr{\"a}valenz der CKD in einer Studienpopulation von KHK-Patienten im Raum W{\"u}rzburg zu beschreiben. Nach den KDIGO-Leitlinien wurden die Patienten mit einer eGFRCKD-EPI<60ml/min als CKD-Patienten eingestuft. Zus{\"a}tzlich wurde der Albumin/Kreatinin-Quotient (ACR) bestimmt. Zusammenh{\"a}nge zwischen der Nierenfunktion und m{\"o}glichen Determinanten wurden untersucht. Mit Hilfe eines Fragebogens wurde die Patienten-Awareness beschrieben. Retrospektiv erfolgte die Recherche, ob die Diagnose der CKD bei Aufnahme und/oder Entlassung des Indexaufenthalts im Arztbrief vermerkt wurde, dies wurde als Awareness der CKD seitens des behandelnden Arztes im Krankenhaus gewertet. 25\% der 536-Teilnehmer wiesen am Tag der Untersuchung eine CKD auf. Das mediane Alter betrug 69 Jahre und die mediane eGFR lag bei 74 ml/min. Der ACR war mit 8,3 mg/g in der CKD-Gruppe deutlich erh{\"o}ht (p<0,01). Das mediane Alter (p<0,01) und auch der prozentuale Anteil an Diabetikern (<0,01) waren in der CKD-Gruppe signifikant h{\"o}her. 42,7\% der Patienten mit CKD wussten von ihrer Nierenfunktionseinschr{\"a}nkung Bescheid. Bei 34 der 79 Patienten, die zum Zeitpunkt der Entlassung eine eGFR <60ml/min aufwiesen, wurde eine CKD im Arztbrief erw{\"a}hnt. Die vorliegende Studie zeigt eine hohe Pr{\"a}valenz von CKD und klassischen kardiovaskul{\"a}ren Risikofaktoren wie beispielsweise Diabetes Mellitus. Trotz dieses hohen CKD-Anteils war sich nur ein geringer Teil der Patienten ihrer Nierenfunktionseinschr{\"a}nkung bewusst und wurde nur in geringem Maße von {\"A}rzten im Entlassungsbrief erw{\"a}hnt. Insgesamt war sowohl eine vermehrte Wahrnehmung der CKD seitens der Patienten als auch eine h{\"a}ufigere Erw{\"a}hnung von CKD im Arztbrief mit zunehmendem Schweregrad der CKD assoziiert.}, subject = {Chronische Niereninsuffizienz}, language = {de} } @article{GybergDeBacquerDeBackeretal.2015, author = {Gyberg, Viveca and De Bacquer, Dirk and De Backer, Guy and Jennings, Catriona and Kotseva, Kornelia and Mellbin, Linda and Schnell, Oliver and Tuomilehto, Jaakko and Wood, David and Ryden, Lars and Amouyel, Philippe and Bruthans, Jan and Conde, Almudena Castro and Cifkova, Renata and Deckers, Jaap W. and De Sutter, Johan and Dilic, Mirza and Dolzhenko, Maryna and Erglis, Andrejs and Fras, Zlatko and Gaita, Dan and Gotcheva, Nina and Goudevenos, John and Heuschmann, Peter and Laucevicius, Aleksandras and Lehto, Seppo and Lovic, Dragan and Milicic, Davor and Moore, David and Nicolaides, Evagoras and Oganov, Raphae and Pajak, Andrzej and Pogosova, Nana and Reiner, Zeljko and Stagmo, Martin and St{\"o}rk, Stefan and Tokg{\"o}zoglu, Lale and Vulic, Dusko}, title = {Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology}, series = {Cardiovascular Diabetology}, volume = {14}, journal = {Cardiovascular Diabetology}, number = {133}, doi = {10.1186/s12933-015-0296-y}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-141358}, year = {2015}, abstract = {Background: In order to influence every day clinical practice professional organisations issue management guidelines. Cross-sectional surveys are used to evaluate the implementation of such guidelines. The present survey investigated screening for glucose perturbations in people with coronary artery disease and compared patients with known and newly detected type 2 diabetes with those without diabetes in terms of their life-style and pharmacological risk factor management in relation to contemporary European guidelines. Methods: A total of 6187 patients (18-80 years) with coronary artery disease and known glycaemic status based on a self reported history of diabetes (previously known diabetes) or the results of an oral glucose tolerance test and HbA1c (no diabetes or newly diagnosed diabetes) were investigated in EUROASPIRE IV including patients in 24 European countries 2012-2013. The patients were interviewed and investigated in order to enable a comparison between their actual risk factor control with that recommended in current European management guidelines and the outcome in previously conducted surveys. Results: A total of 2846 (46 \%) patients had no diabetes, 1158 (19 \%) newly diagnosed diabetes and 2183 (35 \%) previously known diabetes. The combined use of all four cardioprotective drugs in these groups was 53, 55 and 60 \%, respectively. A blood pressure target of <140/90 mmHg was achieved in 68, 61, 54 \% and a LDL-cholesterol target of <1.8 mmol/L in 16, 18 and 28 \%. Patients with newly diagnosed and previously known diabetes reached an HbA1c <7.0 \% (53 mmol/mol) in 95 and 53 \% and 11 \% of those with previously known diabetes had an HbA1c >9.0 \% (>75 mmol/mol). Of the patients with diabetes 69 \% reported on low physical activity. The proportion of patients participating in cardiac rehabilitation programmes was low (approximate to 40 \%) and only 27 \% of those with diabetes had attended diabetes schools. Compared with data from previous surveys the use of cardioprotective drugs had increased and more patients were achieving the risk factor treatment targets. Conclusions: Despite advances in patient management there is further potential to improve both the detection and management of patients with diabetes and coronary artery disease.}, language = {en} } @article{HillmannWiedmannFraseretal.2015, author = {Hillmann, Steffi and Wiedmann, Silke and Fraser, Alec and Baeza, Juan and Rudd, Anthony and Norrving, Bo and Asplund, Kjell and Niewada, Maciej and Dennis, Martin and Hermanek, Peter and Wolfe, Charles D. A. and Heuschmann, Peter U.}, title = {Temporal changes in the quality of acute stroke care in five national audits across Europe}, series = {BioMed Research International}, volume = {2015}, journal = {BioMed Research International}, number = {432497}, doi = {10.1155/2015/432497}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-149059}, year = {2015}, abstract = {Background. Data on potential variations in delivery of appropriate stroke care over time are scarce. We investigated temporal changes in the quality of acute hospital stroke care across five national audits in Europe over a period of six years. Methods. Data were derived from national stroke audits in Germany, Poland, Scotland, Sweden, and England/Wales/Northern Ireland participating within the European Implementation Score (EIS) collaboration. Temporal changes in predefined quality indicators with comparable information between the audits were investigated. Multivariable logistic regression analyses were performed to estimate adherence to quality indicators over time. Results. Between 2004 and 2009, individual data from 542,112 patients treated in 538 centers participating continuously over the study period were included. In most audits, the proportions of patients who were treated on a SU, were screened for dysphagia, and received thrombolytic treatment increased over time and ranged from 2-fold to almost 4-fold increase in patients receiving thrombolytic therapy in 2009 compared to 2004. Conclusions. A general trend towards a better quality of stroke care defined by standardized quality indicators was observed over time. The association between introducing a specific measure and higher adherence over time might indicate that monitoring of stroke care performance contributes to improving quality of care.}, language = {en} } @article{WiedmannHeuschmannHermanek2015, author = {Wiedmann, Silke and Heuschmann, Peter U. and Hermanek, Peter}, title = {In reply: The quality of acute stroke treatment-an analysis of evidence-based indicators in 260 000 patients}, series = {Deutsches Aerzteblatt International}, volume = {112}, journal = {Deutsches Aerzteblatt International}, doi = {10.3238/arztebl.2015.0288b}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-148666}, pages = {288}, year = {2015}, abstract = {No abstract available.}, language = {en} } @phdthesis{Appel2018, author = {Appel, Patricia}, title = {Gef{\"a}hrdungsbeurteilung psychischer Belastung im Gesundheitswesen: Faktorielle Struktur des Kurzfragebogens zur Arbeitsanalyse (KFZA)}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-143815}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2018}, abstract = {Hintergrund. Die gesetzlich vorgeschriebene Gef{\"a}hrdungsbeurteilung psychischer Belastung gewinnt zunehmend an Bedeutung. Ein Standardinstrument, das in diesem Rahmen seit einigen Jahren zur Anwendung kommt, ist der Kurzfragebogens zur Arbeitsanalyse (KFZA), von Pr{\"u}mper et al. (1995). Dieser Fragebogen wurde urspr{\"u}nglich f{\"u}r die Beurteilung von Bildschirmarbeitspl{\"a}tzen konzipiert und f{\"u}r diese Berufsgruppe validiert. Ziel der vorliegenden Arbeit war es, die faktorielle Validit{\"a}t des KFZA bei einem Einsatz im Gesundheitswesen mittels einer explorativen Faktorenanalyse zu {\"u}berpr{\"u}fen. Da eine Fragebogenversion zum Einsatz kam, die zus{\"a}tzlich spezifische Erg{\"a}nzungsfragen f{\"u}r das Gesundheitswesen enthielt, sollte in einem zweiten Schritt auch dieser erweiterte KFZA einer Faktorenanalyse unterzogen werden. Methodik. Insgesamt 1731 Datens{\"a}tze waren {\"u}ber einen Zeitraum von zehn Jahren in verschiedenen norddeutschen Krankenh{\"a}usern als Routinedaten erhoben worden. Nach listenweisem Fallausschluss in Folge des Einsatzes unterschiedlicher Fragebogenvarianten standen f{\"u}r den KFZA 1163 Datens{\"a}tze und davon 1095 Datens{\"a}tze f{\"u}r den erweiterten KFZA zur faktorenanalytischen Auswertung zur Verf{\"u}gung. Die 26 Items des KFZA bzw. die 37 Items der erweiterten Version wurden einer explorativen Faktorenanalyse nach der Hauptkomponentenmethode unterzogen. Die Zahl der Faktoren wurde sowohl mittels Kaiser- als auch Scree-Kriterium bestimmt. F{\"u}r die Interpretation der Faktoren wurden diese sowohl orthogonal nach der Varimax-Methode als auch direct-oblimin rotiert. Zur Absch{\"a}tzung der Reliabilit{\"a}t wurde die interne Konsistenz anhand des Cronbach-α-Koeffizienten berechnet. Ergebnisse. F{\"u}r die 26 Items des KFZA f{\"u}hrte das Kaiser-Kriterium zu einer 7-Faktoren-L{\"o}sung mit einer Gesamtvarianzaufkl{\"a}rung von 62,0\%, der Scree-Plot dagegen deutete auf vier Faktoren hin. Orthogonale und oblique Rotation brachten vergleichbare Ergebnisse. Die inhaltliche Interpretation unterst{\"u}tzte die Anzahl von sieben Faktoren, die wie folgt benannt wurden: „Soziale Beziehungen", „Handlungsspielraum", „Partizipations- und Entwicklungs-m{\"o}glichkeiten", „Quantitative Arbeitsbelastungen", „Umgebungsbelastungen", „Vielseitigkeit" und „Qualitative Arbeitsbelastungen". F{\"u}r diese Skalen, die jeweils 2 bis 6 Items umfassten, konnten Cronbach-α-Koeffizienten zwischen 0,63 und 0,80 ermittelt werden. Die Faktorenanalyse des erweiterten KFZA mit insgesamt 37 Items f{\"u}hrte nach Bestimmung des Kaiser-Kriteriums und Betrachtung der inhaltlichen Plausibilit{\"a}t zu einer 9-Faktoren-L{\"o}sung mit einer Gesamtvarianzaufkl{\"a}rung von 59,5\%. Die beiden zus{\"a}tzlichen Faktoren wurden mit „Fehlbeanspruchungsfolgen" und „Emotionale Belastungen" benannt. Die Werte des Cronbach-α-Koeffizienten lagen f{\"u}r diese Skalen zwischen 0,63 und 0,87. Diskussion. Statt der von den Autoren des KFZA beschriebenen elf Faktoren wurden bei einem Einsatz im Gesundheitswesen sieben Faktoren ermittelt. Auch wenn sich die Anzahl der Faktoren reduzierte, ließ sich die Struktur inhaltlich relativ gut replizieren. Besonders die Items des KFZA-Faktors „Ganzheitlichkeit" erwiesen sich jedoch f{\"u}r den Einsatz im Gesundheitswesen als nicht passgenau. Die Erg{\"a}nzungsitems des erweiterten KFZA bildeten zwei zus{\"a}tzliche Faktoren bzw. ließen sich den zuvor ermittelten Faktoren sinnvoll zuordnen. Die vorliegende Arbeit liefert somit einen Beitrag zur Einsch{\"a}tzung der Validit{\"a}t dieses in der Praxis h{\"a}ufig eingesetzten Instruments. Die psychometrische Pr{\"u}fung kann jedoch noch nicht als vollst{\"a}ndig erachtet werden und sollte in nachfolgenden Studien fortgef{\"u}hrt werden.}, subject = {Psychische Belastung}, language = {de} } @article{SmithBrayHoffmanetal.2015, author = {Smith, Craig J. and Bray, Benjamin D. and Hoffman, Alex and Meisel, Andreas and Heuschmann, Peter U. and Wolfe, Charles D. A. and Tyrrell, Pippa J. and Rudd, Anthony G.}, title = {Can a novel clinical risk score improve pneumonia prediction in acute stroke care? A UK multicenter cohort study}, series = {Journal of the American Heart Association}, volume = {4}, journal = {Journal of the American Heart Association}, number = {1}, doi = {10.1161/JAHA.114.001307}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-144602}, pages = {e001307}, year = {2015}, abstract = {Background Pneumonia frequently complicates stroke and has amajor impact on outcome. We derived and internally validated a simple clinical risk score for predicting stroke-associated pneumonia (SAP), and compared the performance with an existing score (A\(^{2}\)DS\(^{2}\)). Methods and Results We extracted data for patients with ischemic stroke or intracerebral hemorrhage from the Sentinel Stroke National Audit Programme multicenter UK registry. The data were randomly allocated into derivation (n=11 551) and validation (n=11 648) samples. A multivariable logistic regression model was fitted to the derivation data to predict SAP in the first 7 days of admission. The characteristics of the score were evaluated using receiver operating characteristics (discrimination) and by plotting predicted versus observed SAP frequency in deciles of risk (calibration). Prevalence of SAP was 6.7\% overall. The final 22-point score (ISAN: prestroke Independence [modified Rankin scale], Sex, Age, National Institutes of Health Stroke Scale) exhibited good discrimination in the ischemic stroke derivation (C-statistic 0.79; 95\% CI 0.77 to 0.81) and validation (C-statistic 0.78; 95\% CI 0.76 to 0.80) samples. It was well calibrated in ischemic stroke and was further classified into meaningful risk groups (low 0 to 5, medium6 to 10, high 11 to 14, and very high >= 15) associated with SAP frequencies of 1.6\%, 4.9\%, 12.6\%, and 26.4\%, respectively, in the validation sample. Discrimination for both scores was similar, although they performed less well in the intracerebral hemorrhage patients with an apparent ceiling effect. Conclusions The ISAN score is a simple tool for predicting SAP in clinical practice. External validation is required in ischemic and hemorrhagic stroke cohorts.}, language = {en} } @phdthesis{Hochreuter2016, author = {Hochreuter, Anna-Katharina}, title = {Trost im Klinikalltag. Eine qualitative Untersuchung zur Sterbebegleitung}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-140084}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2016}, abstract = {Das Ziel der vorliegenden Arbeit ist es, den Stellenwert von Trost im Umgang mit Patienten und Angeh{\"o}rigen aufzuzeigen und mittels einer empirischen Untersuchung zur Sterbebegleitung festzustellen, wie dies in der Realit{\"a}t im Klinikalltag umgesetzt wird. Hierf{\"u}r wurde die Sterbebegleitung auf zwei unterschiedlichen Stationen innerhalb eines Krankenhauses qualitativ ausgewertet. Der theoretische Teil der vorliegenden Arbeit zeigt anhand wissenschaftlicher Daten, welche unterschiedlichen Bed{\"u}rfnisse schwerstkranke und sterbende Patienten und ihre Angeh{\"o}rigen an den Arzt im Hinblick auf Trost haben und wie diesen angemessen begegnet werden kann. Mittels teilstrukturiertem Leitfadeninterview wurden {\"A}rzte und Pflegekr{\"a}fte als Experten dazu befragt, wie die Begleitung sterbender Patienten und ihrer Angeh{\"o}rigen aussieht und wie sie den Betroffenen Trost spenden. Die Aspekte Zeit, Raum, Personal und Ausbildung und ihr Einfluss auf die Begleitung wurden thematisiert. Zuletzt wurden die Experten nach ihrer Vorstellung von einem w{\"u}rdevollen Sterben im Krankenhaus und Ans{\"a}tzen zur Verbesserung des Umgangs mit sterbenden Patienten und ihren Angeh{\"o}rigen gefragt. Nach dem Prinzip des Theoretical Sampling der Grounded Theory nach Glaser und Strauss wurde die Sterbebegleitung auf einer Normal- und einer Palliativstation gegen{\"u}bergestellt. Insgesamt wurden vier {\"A}rzte und acht Pflegekr{\"a}fte interviewt. Das Sampling pro Gruppe wurde beendet, nachdem die theoretische S{\"a}ttigung erreicht war. Die Auswertung der Interviews erfolgte nach dem Prinzip von Meuser und Nagel. Es wurde untersucht, wie Trost in der Begleitung sterbender Patienten und ihrer Angeh{\"o}rigen gestaltet wird. Unterschiede zwischen den beiden Stationen wurden herausgearbeitet und analysiert, worauf diese zur{\"u}ckzuf{\"u}hren sind. L{\"o}sungsans{\"a}tze f{\"u}r eine Verbesserung der Situation im Krankenhaus wurden konzipiert. Das Ergebnis der Untersuchung zeigt, dass sich alle befragten {\"A}rzte und Pflegekr{\"a}fte der existentiellen Ausnahmesituation von Sterbenden und Angeh{\"o}rigen bewusst sind und ein hohes Maß an Bereitschaft vorhanden ist, eine ad{\"a}quate Begleitung zu gew{\"a}hrleisten. Die M{\"o}glichkeiten der Sterbebegleitung auf der Palliativstation werden insgesamt als gut bewertet. Im Mittelpunkt steht die individuelle Begleitung des sterbenden Patienten und seiner Angeh{\"o}rigen. Bem{\"a}ngelt werden ein teilweise zu hoher Patientendurchlauf und eine zu geringe pflegerische Besetzung im Nachtdienst. Im Gegensatz dazu wird die Arbeit der Begleiter auf der Normalstation durch den niedrigeren Personalschl{\"u}ssel und die gegebenen R{\"a}umlichkeiten limitiert. Problematisch ist vor allem die mangelnde Ausbildung im Umgang mit Sterbenden und Angeh{\"o}rigen. Um die Situation in Krankenh{\"a}usern, insbesondere auf den Normalstationen zu verbessern, sollte ein gesellschaftliches Umdenken stattfinden. Voraussetzung hierf{\"u}r ist das Bewusstsein und die Akzeptanz, dass Sterben unabdingbar zum Leben geh{\"o}rt und somit auf jeder Station eines Krankenhauses stattfindet. Auf politischen Ebenen k{\"o}nnen entsprechende Maßnahmen in die Wege geleitet und die notwendigen Mittel bereitgestellt werden, damit nicht nur auf Palliativ- sondern auch auf Normalstationen geschultes Personal und geeignete R{\"a}umlichkeiten zur Verf{\"u}gung stehen, um allen sterbenden Patienten und ihren Angeh{\"o}rigen eine bestm{\"o}gliche Begleitung zuteilwerden zu lassen.}, subject = {Trost}, language = {de} } @phdthesis{Raevskaia2020, author = {Raevskaia, Sofia}, title = {{\"U}berlebensrate parodontal schwer vorgesch{\"a}digter Z{\"a}hne unter regelm{\"a}ßiger parodontaler Erhaltungstherapie}, doi = {10.25972/OPUS-20013}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-200138}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2020}, abstract = {Diese Studie sollte die {\"U}berlebensrate parodontal schwer vorgesch{\"a}digter parodontaler Taschen pr{\"u}fen. Untersucht wurde anhand von Patienten aus dem Studentenkurs der Parodontologie in W{\"u}rzburg, die eine nicht-chirurgische Parodontitistherapie nach dem W{\"u}rzburger Behandlungskonzept erhielten. Ausgew{\"a}hlt wurden alle Patienten, die zum Zeitpunkt ihrer Initialtherapie parodontale Taschen mit einer Sondierungstiefe von 8 mm oder mehr aufwiesen. Nach diesem Kriterium ergab die Ermittlung ganzer Behandlungsjahrg{\"a}nge 179 Patienten mit dem durchschnittlichen Alter von ca. 57 Jahren, die sich in den Jahren 2008, 2009, 2011 und 2012 erstmals aufgrund von Parodontitis behandeln ließen. Alle untersuchten Patienten durchliefen das Standardprocedere der Initialtherapie und einer Reevaluation. Die meisten Patienten nahmen an dem f{\"u}r gew{\"o}hnlich bis zu zwei Mal j{\"a}hrlich stattfindenden Recallterminen mehr oder weniger regelm{\"a}ßig teil, was die Alltagsrealit{\"a}t in den deutschen Zahnarztpraxen wiederspiegelt. Die Untersuchung beinhaltet insgesamt 627 Z{\"a}hne mit 1331 parodontalen Taschen. Ihre Auswertung erfolgte durch die Kaplan-Meier-Sch{\"a}tzung. Diese ist eine {\"U}berlebenszeitanalyse, die die Wahrscheinlichkeit f{\"u}r das Eintreffen eines oder mehrerer vorausgew{\"a}hlter Ereignisse berechnet. Diese Ereignisse wurden in dieser Untersuchung durch die f{\"u}r die parodontale Stabilit{\"a}t wichtigen Sondierungstiefen (5 mm und weniger, 5-8 mm und 8mm und gr{\"o}ßer) definiert. Der Vorteil dieser Auswertungsmethode besteht darin, dass alle Patienten bis zum Zeitpunkt ihrer letzten Behandlung in die Untersuchung einbezogen werden und dass die Zielereignisse variabel definiert werden k{\"o}nnen. In der Hauptanalyse der 179 Patienten beschrieb die {\"U}berlebenskurve der Kaplan-Meier-Sch{\"a}tzung den positiven Effekt des Behandlungskonzeptes. Nach drei Jahren lag die Wahrscheinlichkeit bei 65,7 \% f{\"u}r das Erreichen von Sondierungstiefen 5 mm oder weniger, was den Bereich der parodontalen Stabilit{\"a}t darstellt. Selbst unter der am meisten pessimistischen Annahme erreichten nach drei Jahren knapp ein Drittel aller Patienten den Bereich der parodontalen Stabilit{\"a}t.}, subject = {Parodontitis}, language = {de} } @phdthesis{Hardoerfer2018, author = {Hard{\"o}rfer, Katrin}, title = {Wirksamkeit einer Yogatherapie bei Tumorpatienten auf Angst, Depressivit{\"a}t und Fatigue - eine randomisierte kontrollierte Studie}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-167920}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2018}, abstract = {Viele Tumorpatienten leiden unter Symptomen von Angst, Depressivit{\"a}t und Fatigue. Yoga als komplement{\"a}re und alternative Medizin ist in den letzten Jahren immer mehr in den Fokus der Forschung ger{\"u}ckt. Es wurden schon zahlreiche Studien durchgef{\"u}hrt, die kurzfristige Effekte bei Tumorpatienten zeigen konnten. Diese Ergebnisse beschr{\"a}nkten sich jedoch zumeist auf Brustkrebspatientinnen und konnten daher noch nicht verallgemeinert und so f{\"u}r ein breites klinisches Setting zug{\"a}nglich gemacht werden. Die vorliegende Dissertation untersuchte die Wirksamkeit einer Yogaintervention bei Tumorpatienten unterschiedlicher Tumorentit{\"a}t. Die Effekte auf die Belastun¬gen Angst, Depressivit{\"a}t und Fatigue wurden betrachtet. Es wurden die Hypo¬thesen formuliert, dass durch eine achtw{\"o}chige Yogaintervention die Outcomes Angst, Depressivit{\"a}t und Fatigue signifikant im Vergleich zur Kontrollgruppe gesenkt werden k{\"o}nnen. Außerdem wurden die Erwartungen an die Yogainter¬vention sowie ihre Bewertung erfragt. Das Studiendesign zur {\"U}berpr{\"u}fung der Hypothesen bestand aus einer rando-misiert kontrollierten Studie mit einer achtw{\"o}chigen Yogaintervention im Vergleich mit einer Wartekontrollgruppe. Die Yogasitzungen dauerten w{\"o}chent¬lich 60 Minuten und wurden in Gruppen von zehn bis zw{\"o}lf Probanden unter der Leitung einer zur Yogatherapeutin ausgebildete Psychoonkologin durchgef{\"u}hrt. Die Yogaintervention enthielt K{\"o}rper- sowie Atem{\"u}bungen und Meditation. Es wurden Selbsteinsch{\"a}tzungsb{\"o}gen zum Pr{\"a}- und Postinterventionszeitpunkt verwandt. Angstsymptome wurden mit dem GAD-7-Fragebogen, Depressivit{\"a}t mit dem PHQ-2-Fragebogen und Fatigue mit dem EORTC-QLQ FA13-Fragebogen ermittelt. Die Kontrollgruppe erhielt eine Yogatherapie nach dem achtw{\"o}chigen Wartezeitraum. Die Stichprobe beinhaltete gemischte Diagnosen und fast die H{\"a}lfte der Probanden wies eine andere Tumorentit{\"a}t als Mammakarzinom auf. 90\% der Teilnehmer bildeten Frauen. In der Interventionsgruppe konnte im Vergleich zur Kontrollgruppe auf Angst ein großer signifikanter Effekt gefunden werden. Depressivit{\"a}t und Fatigue zeigten keinen signifikanten Effekt. Die Yogatherapie wurde, vor allem hinsichtlich Aufbau und Anleitung, {\"u}berwiegend gut bewertet und die Erwartungen erf{\"u}llt. Aus den Befragungen ging hervor, dass die Teil¬nehmer subjektiv von der Yogaintervention profitierten und selbst Yoga weiter durchf{\"u}hren m{\"o}chten sowie die Yogaintervention auch anderen Tumorpatienten weiterempfehlen w{\"u}rden. Zusammenfassend kann man aus dieser Studie schließen, dass eine Yoga-intervention eine vielversprechende, supportive Therapie zu sein scheint. Eine Verallgemeinerung der Ergebnisse f{\"u}r ein breites klinisches Setting konnte vor allem mit dem hohen Frauenanteil und dem hohen Anteil an Brustkrebs-patientinnen nicht ohne weiteres vorgenommen werden. Es bedarf weiterer Forschung, die ihren Schwerpunkt auf gr{\"o}ßer angelegte Stichproben mit ver-schiedenen Tumorentit{\"a}ten und einem ausgeglichenen Geschlechterverh{\"a}ltnis legt.}, subject = {Yoga}, language = {de} } @article{BeckerRauSchmittetal.2015, author = {Becker, Philip P. and Rau, Monika and Schmitt, Johannes and Malsch, Carolin and Hammer, Christian and Bantel, Heike and M{\"u}llhaupt, Beat and Geier, Andreas}, title = {Performance of serum microRNAs -122, -192 and -21 as biomarkers in patients with non-alcoholic steatohepatitis}, series = {PLoS ONE}, volume = {10}, journal = {PLoS ONE}, number = {11}, doi = {10.1371/journal.pone.0142661}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-145147}, pages = {e0142661}, year = {2015}, abstract = {Objectives Liver biopsies are the current gold standard in non-alcoholic steatohepatitis (NASH) diagnosis. Their invasive nature, however, still carries an increased risk for patients' health. The development of non-invasive diagnostic tools to differentiate between bland steatosis (NAFL) and NASH remains crucial. The aim of this study is the evaluation of investigated circulating microRNAs in combination with new targets in order to optimize the discrimination of NASH patients by non-invasive serum biomarkers. Methods Serum profiles of four microRNAs were evaluated in two cohorts consisting of 137 NAFLD patients and 61 healthy controls. In a binary logistic regression model microRNAs of relevance were detected. Correlation of microRNA appearance with known biomarkers like ALT and CK18-Asp396 was evaluated. A simplified scoring model was developed, combining the levels of microRNA in circulation and CK18-Asp396 fragments. Receiver operating characteristics were used to evaluate the potential of discriminating NASH. Results The new finding of our study is the different profile of circulating miR-21 in NASH patients (p<0.0001). Also, it validates recently published results of miR-122 and miR-192 to be differentially regulated in NAFL and NASH. Combined microRNA expression profiles with CK18-Asp396 fragment level scoring model had a higher potential of NASH prediction compared to other risk biomarkers (AUROC = 0.83, 95\% CI = 0.754-0.908; p<0.001). Evaluation of score model for NAFL (Score = 0) and NASH (Score = 4) had shown high rates of sensitivity (91\%) and specificity (83\%). Conclusions Our study defines candidates for a combined model of miRNAs and CK18-Asp396 levels relevant as a promising expansion for diagnosis and in turn treatment of NASH.}, language = {en} } @phdthesis{Duelli2018, author = {Duelli, Kristin}, title = {Der Zusammenhang von soziodemografischen, krankheitsbezogenen und psychosozialen Risikofaktoren mit der psychischen Belastung und dem Wunsch nach psychosozialer Unterst{\"u}tzung bei Brustkrebspatientinnen}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-171686}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2018}, abstract = {Ziel der vorliegenden Arbeit ist es soziodemografische, krankheitsbezogene und psychosozi¬ale Variablen, die in Zusammenhang mit der psychischen Belastung und dem Wunsch nach psychosozialer Unterst{\"u}tzung stehen, von Brustkrebspatientinnen zu identifi¬zieren. Dabei werden in der vorliegenden Arbeit die Art der Erkrankung, die k{\"o}rperli¬che Leistungsf{\"a}higkeit, die funktionelle soziale Unterst{\"u}tzung, unterteilt in posi-tive Unterst{\"u}tzung und belastende Interaktionen, der Familienstand bzw. die Partner-schaft und das Vorhandensein von Kindern als unabh{\"a}ngige Variablen n{\"a}her untersucht. Aus einer Baseline-Erhebung einer L{\"a}ngsschnittstudie aus Deutschland, die unter ande-rem auch Patienten in der Universit{\"a}ts-Frauenklinik in W{\"u}rzburg rekrutiert hat, gehen 27 Brustkrebspatientinnen in die Auswertung der vorliegenden Arbeit mit ein. Zudem entstammen weitere Daten von 202 Brustkrebspatienten aus einer vorangegangenen multizentrischen Querschnittsstudie, deren Rekrutierung ebenfalls in der Frauenklinik stattfand. Die Stichprobe umfasst insgesamt 229 Patienten mit einem Altersdurchschnitt von 55,22 Jahren. Die Erfassung des Wunsches nach psychosozialer Unterst{\"u}tzung er-folgte mittels 3 spezifischen Fragen. Diese beinhalten das Bed{\"u}rfnis nach psychosozialer Unterst{\"u}tzung und erfragen die Akzeptanz eines solchen Angebots sowie den Wunsch, mit jemandem {\"u}ber die psychi-sche Belastung durch die Erkrankung zu sprechen. Die psychische Belastung wurde mit dem PHQ-9-Fragebogen zur Erfassung der Depressivi¬t{\"a}t und dem GAD-7-Fragebogen zur Erfassung der Angst, gemessen. Die Untersuchung brachte folgende Ergebnisse: Die belastenden Interaktionen der sozia¬len Unterst{\"u}tzung stehen in signifikantem Zusammenhang mit dem Schwergrad der psychischen Belastung, sowohl im PHQ-9-Fragebogen {\"u}ber Depressivit{\"a}t als auch beim GAD-7- Selbstbeurteilungsinstrument zur Erfassung der Angst. Ebenso ist ein signifikanter negativer Zusammenhang mit schwach bis mittelstarker Effektst{\"a}rke zwischen der positiven funktionellen Unterst{\"u}tzung und dem Ausmaß der Angst-symptomatik vorhanden. Auch der Kar¬nofsky-Index weist einen signifikanten Zusammenhang mit der Depressivit{\"a}t auf und einen nicht-signifikanten Trend bez{\"u}glich Angstsymptomen. Keine Zusammenh{\"a}nge finden sich mit der Art der Erkrankung, dem Familien¬stand bzw. dem Vorhandensein einer Partnerschaft, sowie dem Vorhandensein von Kindern. In Bezug auf das Bed{\"u}rfnis, die Akzeptanz und den Wunsch nach psychosozia¬ler Unterst{\"u}tzung konnten ebenfalls keine signifikanten Zusammenh{\"a}nge mit den oben genannten soziodemografischen, psychosozialen und krankheitsbezoge¬nen Variablen festgestellt werden. Die Ergebnisse stimmen teilweise mit bisherigen Studien {\"u}berein. Die Abweichungen, die zu anderen Publikationen bestehen, sind weitestgehend auf Unterschiede im Rahmen der Stichproben und der Messinstrumente zur{\"u}ckzuf{\"u}hren. Zuk{\"u}nftige Publikationen sollten in Form von Longitudinalstudien den zeitlichen Verlauf der Einflussfaktoren auf die abh{\"a}ngigen Variablen n{\"a}her untersuchen. Zudem w{\"a}re eine Vereinheitlichung der Messmethoden f{\"u}r einen besseren Vergleich der Ergebnisse unter¬schiedlicher Studien untereinander ratsam. Außerdem sollte auch f{\"u}r den klinischen Bereich zuk{\"u}nftige Bestrebungen sein, weitere Leitlinien zum Thema psychoonkologische Unterst{\"u}tzung zu etablieren, Wege zu finden dem medizinischen Personal das Erkennen psychischer Belastung bei Patienten und deren Bed{\"u}rfnis nach Unterst{\"u}tzung zu erleichtern und die Integration psychosozialer Betreuungs- und Unterst{\"u}tzungsangebote im klinischen Alltag zu verst{\"a}rken}, subject = {Soziale Unterst{\"u}tzung}, language = {de} } @article{MagyarWagnerThomasetal.2019, author = {Magyar, Attila and Wagner, Martin and Thomas, Phillip and Malsch, Carolin and Schneider, Reinhard and St{\"o}rk, Stefan and Heuschmann, Peter U and Leyh, Rainer G and Oezkur, Mehmet}, title = {HO-1 concentrations 24 hours after cardiac surgery are associated with the incidence of acute kidney injury: a prospective cohort study}, series = {International Journal of Nephrology and Renovascular Disease}, volume = {12}, journal = {International Journal of Nephrology and Renovascular Disease}, doi = {10.2147/IJNRD.S165308}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-177250}, pages = {9-18}, year = {2019}, abstract = {Background: Acute kidney injury (AKI) is a serious complication after cardiac surgery that is associated with increased mortality and morbidity. Heme oxygenase-1 (HO-1) is an enzyme synthesized in renal tubular cells as one of the most intense responses to oxidant stress linked with protective, anti-inflammatory properties. Yet, it is unknown if serum HO-1 induction following cardiac surgical procedure involving cardiopulmonary bypass (CPB) is associated with incidence and severity of AKI. Patients and methods: In the present study, we used data from a prospective cohort study of 150 adult cardiac surgical patients. HO-1 measurements were performed before, immediately after and 24 hours post-CPB. In univariate and multivariate analyses, the association between HO-1 and AKI was investigated. Results: AKI with an incidence of 23.3\% (35 patients) was not associated with an early elevation of HO-1 after CPB in all patients (P=0.88), whereas patients suffering from AKI developed a second burst of HO-1 24 hours after CBP. In patients without AKI, the HO-1 concentrations dropped to baseline values (P=0.031). Furthermore, early HO-1 induction was associated with CPB time (P=0.046), while the ones 24 hours later lost this association (P=0.219). Conclusion: The association of the second HO-1 burst 24 hours after CBP might help to distinguish between the causality of AKI in patients undergoing CBP, thus helping to adapt patient stratification and management.}, language = {en} } @article{MaggRieglerWiedmannetal.2015, author = {Magg, Barbara and Riegler, Christoph and Wiedmann, Silke and Heuschmann, Peter and Sommer, Claudia and {\"U}{\c{c}}eyler, Nurcan}, title = {Self-administered version of the Fabry-associated pain questionnaire for adult patients}, series = {Orphanet Journal of Rare Diseases}, volume = {10}, journal = {Orphanet Journal of Rare Diseases}, number = {113}, doi = {10.1186/s13023-015-0325-7}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-145294}, year = {2015}, abstract = {Background Fabry-associated pain may be the first symptom of Fabry disease (FD) and presents with a unique phenotype including mostly acral burning triggerable pain attacks, evoked pain, pain crises, and permanent pain. We recently developed and validated the first Fabry Pain Questionnaire (FPQ) for adult patients. Here we report on the validation of the self-administered version of the FPQ that no longer requires a face-to-face interview but can be filled in by the patients themselves allowing more flexible data collection. Methods At our W{\"u}rzburg Fabry Center for Interdisciplinary Treatment, Germany, we have developed the self-administered version of the FPQ by adapting the questionnaire to a self-report version. To do this, consecutive Fabry patients with current or past pain history (n = 56) were first interviewed face-to-face. Two weeks later patients' self-reported questionnaire results were collected by mail (n = 55). We validated the self-administered version of the FPQ by assessing the inter-rater reliability agreement of scores obtained by supervised administration and self-administration of the FPQ. Results The FPQ contains 15 questions on the different pain phenotypes, on pain development during life with and without therapy, and on impairment due to pain. Statistical analysis showed that the majority of questions were answered in high agreement in both sessions with a mean AC1-statistic of 0.857 for 55 nominal-scaled items and a mean ICC of 0.587 for 9 scores. Conclusions This self-administered version of the first pain questionnaire for adult Fabry patients is a useful tool to assess Fabry-associated pain without a time-consuming face-to-face interview but via a self-reporting survey allowing more flexible usage.}, language = {en} } @article{SonnenscheinvanderVoortArendsdeJongsteetal.2014, author = {Sonnenschein-van der Voort, Agnes M. M. and Arends, Lidia R. and de Jongste, Johan C. and Annesi-Maesano, Isabella and Arshad, S. Hasan and Barros, Henrique and Basterrechea, Mikel and Bisgaard, Hans and Chatzi, Leda and Corpeleijn, Eva and Correia, Sofia and Craig, Leone C. and Devereux, Graham and Dogaru, Cristian and Dostal, Miroslav and Duchen, Karel and Eggesb{\o}, Merete and van der Ent, C. Kors and Fantini, Maria P. and Forastiere, Francesco and Frey, Urs and Gehring, Ulrike and Gori, Davide and van der Gugten, Anne C. and Hanke, Wojciech and Henderson, A. John and Heude, Barbara and I{\~n}iguez, Carmen and Inskip, Hazel M. and Keil, Thomas and Kelleher, Cecily C. and Kogevinas, Manolis and Kreiner-M{\o}ller, Eskil and Kuehni, Claudia E. and K{\"u}pers, Leanne K. and Lancz, Kinga and Larsen, Pernille S. and Lau, Susanne and Ludvigsson, Johnny and Mommers, Monique and Andersen, Anne-Marie Nybo and Palkovicova, Lubica and Pike, Katherine C. and Pizzi, Constanza and Polanska, Kinga and Porta, Daniela and Richiardi, Lorenzo and Roberts, Graham and Schmidt, Anne and Sram, Radim J. and Sunyer, Jordi and Thijs, Carel and Torrent, Maties and Viljoen, Karien and Wijga, Alet H. and Vrijheid, Martine and Jaddoe, Vincent W. V. and Duijts, Liesbeth}, title = {Preterm birth, infant weight gain, and childhood asthma risk: A meta-analysis of 147,000 European children}, series = {The Journal of Allergy and Clinical Immunology}, volume = {133}, journal = {The Journal of Allergy and Clinical Immunology}, number = {5}, doi = {10.1016/j.jaci.2013.12.1082}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-120714}, pages = {1317-29}, year = {2014}, abstract = {Background Preterm birth, low birth weight, and infant catch-up growth seem associated with an increased risk of respiratory diseases in later life, but individual studies showed conflicting results. Objectives We performed an individual participant data meta-analysis for 147,252 children of 31 birth cohort studies to determine the associations of birth and infant growth characteristics with the risks of preschool wheezing (1-4 years) and school-age asthma (5-10 years). Methods First, we performed an adjusted 1-stage random-effect meta-analysis to assess the combined associations of gestational age, birth weight, and infant weight gain with childhood asthma. Second, we performed an adjusted 2-stage random-effect meta-analysis to assess the associations of preterm birth (gestational age <37 weeks) and low birth weight (<2500 g) with childhood asthma outcomes. Results Younger gestational age at birth and higher infant weight gain were independently associated with higher risks of preschool wheezing and school-age asthma (P < .05). The inverse associations of birth weight with childhood asthma were explained by gestational age at birth. Compared with term-born children with normal infant weight gain, we observed the highest risks of school-age asthma in children born preterm with high infant weight gain (odds ratio [OR], 4.47; 95\% CI, 2.58-7.76). Preterm birth was positively associated with an increased risk of preschool wheezing (pooled odds ratio [pOR], 1.34; 95\% CI, 1.25-1.43) and school-age asthma (pOR, 1.40; 95\% CI, 1.18-1.67) independent of birth weight. Weaker effect estimates were observed for the associations of low birth weight adjusted for gestational age at birth with preschool wheezing (pOR, 1.10; 95\% CI, 1.00-1.21) and school-age asthma (pOR, 1.13; 95\% CI, 1.01-1.27). Conclusion Younger gestational age at birth and higher infant weight gain were associated with childhood asthma outcomes. The associations of lower birth weight with childhood asthma were largely explained by gestational age at birth."}, language = {en} } @article{ChungGedeborgNicholasetal.2014, author = {Chung, Shen-Chia and Gedeborg, Rolf and Nicholas, Owen and James, Stefan and Jeppsson, Anders and Wolfe, Charles and Heuschmann, Peter and Wallentin, Lars and Deanfield, John and Timmis, Adam and Jernberg, Tomas and Hemingway, Harry}, title = {Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK}, series = {Lancet}, volume = {383}, journal = {Lancet}, number = {9925}, doi = {10.1016/s0140-6736(13)62070-x}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-121327}, pages = {1305-12}, year = {2014}, abstract = {Background International research for acute myocardial infarction lacks comparisons of whole health systems. We assessed time trends for care and outcomes in Sweden and the UK. Methods We used data from national registries on consecutive patients registered between 2004 and 2010 in all hospitals providing care for acute coronary syndrome in Sweden and the UK. The primary outcome was all-cause mortality 30 days after admission. We compared effectiveness of treatment by indirect casemix standardisation. This study is registered with ClinicalTrials.gov, number NCT01359033. Findings We assessed data for 119 786 patients in Sweden and 391 077 in the UK. 30-day mortality was 7·6\% (95\% CI 7·4-7·7) in Sweden and 10·5\% (10·4-10·6) in the UK. Mortality was higher in the UK in clinically relevant subgroups defined by troponin concentration, ST-segment elevation, age, sex, heart rate, systolic blood pressure, diabetes mellitus status, and smoking status. In Sweden, compared with the UK, there was earlier and more extensive uptake of primary percutaneous coronary intervention (59\% vs 22\%) and more frequent use of β blockers at discharge (89\% vs 78\%). After casemix standardisation the 30-day mortality ratio for UK versus Sweden was 1·37 (95\% CI 1·30-1·45), which corresponds to 11 263 (95\% CI 9620-12 827) excess deaths, but did decline over time (from 1·47, 95\% CI 1·38-1·58 in 2004 to 1·20, 1·12-1·29 in 2010; p=0·01). Interpretation We found clinically important differences between countries in acute myocardial infarction care and outcomes. International comparisons research might help to improve health systems and prevent deaths.}, language = {en} } @article{GrubeKoenneckeWalteretal.2013, author = {Grube, Maike Miriam and Koennecke, Hans-Christian and Walter, Georg and Meisel, Andreas and Sobesky, Jan and Nolte, Christian Hans and Wellwood, Ian and Heuschmann, Peter Ulrich}, title = {Influence of Acute Complications on Outcome 3 Months after Ischemic Stroke}, series = {PLOS ONE}, volume = {8}, journal = {PLOS ONE}, number = {9}, issn = {1932-6203}, doi = {10.1371/journal.pone.0075719}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-128362}, pages = {e75719}, year = {2013}, abstract = {Background: Early medical complications are potentially modifiable factors influencing in-hospital outcome. We investigated the influence of acute complications on mortality and poor outcome 3 months after ischemic stroke. Methods: Data were obtained from patients admitted to one of 13 stroke units of the Berlin Stroke Registry (BSR) who participated in a 3-months-follow up between June 2010 and September 2012. We examined the influence of the cumulative number of early in-hospital complications on mortality and poor outcome (death, disability or institutionalization) 3 months after stroke using multivariable logistic regression analyses and calculated attributable fractions to determine the impact of early complications on mortality and poor outcome. Results: A total of 2349 ischemic stroke patients alive at discharge from acute care were included in the analysis. Older age, stroke severity, pre-stroke dependency and early complications were independent predictors of mortality 3 months after stroke. Poor outcome was independently associated with older age, stroke severity, pre-stroke dependency, previous stroke and early complications. More than 60\% of deaths and poor outcomes were attributed to age, pre-stroke dependency and stroke severity and in-hospital complications contributed to 12.3\% of deaths and 9.1\% of poor outcomes 3 months after stroke. Conclusion: The majority of deaths and poor outcomes after stroke were attributed to non-modifiable factors. However, early in-hospital complications significantly affect outcome in patients who survived the acute phase after stroke, underlining the need to improve prevention and treatment of complications in hospital.}, language = {en} } @article{SteppuhnLangenScheidtNaveetal.2013, author = {Steppuhn, Henriette and Langen, Ute and Scheidt-Nave, Christa and Keil, Thomas}, title = {Major comorbid conditions in asthma and association with asthma-related hospitalizations and emergency department admissions in adults: results from the German national health telephone interview survey (GEDA) 2010}, series = {BMC Pulmonary Medicine}, volume = {13}, journal = {BMC Pulmonary Medicine}, number = {46}, doi = {10.1186/1471-2466-13-46}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-122121}, year = {2013}, abstract = {Background: It remains unclear to what extent asthma in adults is linked to allergic rhinitis (AR), gastroesophageal reflux disease (GERD), and acetylsalicylic acid exacerbated respiratory disease (AERD), and how these comorbidities may affect asthma outcomes in the general population. We therefore aimed to assess the prevalence of these major comorbidities among adults with asthma and examine their impact on asthma exacerbations requiring hospital care. Methods: A total of 22,050 adults 18 years and older were surveyed in the German National Health Telephone Interview Survey (GEDA) 2010 using a highly standardized computer-assisted interview technique. The study population comprised participants with self-reported physician-diagnosed asthma, among which the current (last 12 months) prevalence of AR and GERD-like symptoms (GERS), and life-time prevalence of AERD was estimated. Weighted bivariate analyses and logistic regression models were applied to assess the association of each comorbid condition with the asthma outcome (any self-reported asthma-related hospitalization and/or emergency department (ED) admission in the past year). Results: Out of 1,136 adults with asthma, 49.6\% had GERS and 42.3\% had AR within the past 12 months; 14.0\% met the criteria of AERD, and 75.7\% had at least one out of the three conditions. Overall, the prevalence of at least one exacerbation requiring emergency room or hospital admission within the past year was 9.0\%. Exacerbation prevalence was higher among participants with comorbidities than among those without (9.8\% vs. 8.2\% for GERS; 11.2\% vs. 7.6\% for AR, and 22.2\% vs. 7.0\% for AERD), but only differences in association with AERD were statistically significant. A strong association between asthma exacerbation and AERD persisted in multivariable logistic regression analyses adjusting for sex, age group, level of body mass index, smoking status, educational attainment, and duration of asthma: odds ratio (OR) = 4.5, 95\% confidence interval (CI) = 2.5-8.2. Conclusions: Data from this large nation-wide study provide evidence that GERS, AR and AERD are all common comorbidities among adults with asthma. Our data underline the public health and clinical impact of asthma with complicating AERD, contributing considerably to disease-specific hospitalization and/or ED admission in a defined asthma population, and emphasize the importance of its recognition in asthma care.}, language = {en} } @article{KristDimeoKeil2013, author = {Krist, Lilian and Dimeo, Fernando and Keil, Thomas}, title = {Can progressive resistance training twice a week improve mobility, muscle strength, and quality of life in very elderly nursing-home residents with impaired mobility? A pilot study}, series = {Clinical Interventions in Aging}, volume = {8}, journal = {Clinical Interventions in Aging}, doi = {10.2147/CIA.S42136}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-122176}, pages = {443-448}, year = {2013}, abstract = {Purpose: To determine the effects of progressive resistance training on mobility, muscle strength, and quality of life in nursing-home residents with impaired mobility. Methods: Nursing-home residents aged 77 years and older with impaired mobility were recruited in Berlin, Germany. The eight-week exercise program consisted of progressive resistance training twice a week. Mobility (primary outcome) was assessed with the Elderly Mobility Scale (zero = worst, 20 = best) at baseline and after 8 weeks. Muscle strength (secondary outcome) was determined by the eight-repetition maximum. The Short Form-36 Health Survey was used to assess quality of life. Results: Of the 15 participants (mean age 84 years, range 77-97 years), ten completed the 8-week program. Mobility (Elderly Mobility Scale mean +/- standard deviation pre 14.1 +/- 3.2 and post 17.5 +/- 3.6; P = 0.005) as well as muscle strength of upper and lower limbs improved (from 62\% at chest press up to 108\% at leg extension machine), whereas most quality of life subscales did not show considerable change. Conclusion: Resistance training twice a week over 2 months seemed to considerably improve mobility and muscle strength in persons aged 77-97 years with impaired mobility.}, language = {en} } @phdthesis{Reimer2015, author = {Reimer, Christine}, title = {Suizidalit{\"a}t bei Krebspatienten und ihre Korrelate}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-125185}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2015}, abstract = {Hintergrund vorliegender Arbeit ist, dass mehrere Studien eine erh{\"o}hte Suizidrate bei Krebspatienten im Vergleich zur Allgemeinbev{\"o}lkerung gezeigt haben. Zu suizidalen Gedanken und Handlungen (Suizidalit{\"a}t) bei Krebspatienten und ihren Risikofaktoren gibt es jedoch nur wenige Studien. Ziel der Arbeit war, die Pr{\"a}valenz von Suizidgedanken bei Krebspatienten festzustellen, und einen Zusammenhang zwischen Suizidalit{\"a}t und den Faktoren Geschlecht, Depressivit{\"a}t, Angst, Distress, Schmerzen, der Inanspruchnahme psychosozialer Unterst{\"u}tzungsangebote sowie bestimmten Tumorlokalisationen zu untersuchen. Die Tumorlokalisationen wurden zwischen Lokalisationen mit erh{\"o}htem vs. nicht erh{\"o}htem Stigmatisierungspotential bzw. Lokalisationen mit besonders negativer vs. nicht besonders negativer Prognose unterschieden. Im Rahmen einer multizentrischen, deutschlandweiten Querschnittstudie wurden Krebspatienten mithilfe des Patient Health Questionnaire (PHQ) hinsichtlich ihrer Suizidalit{\"a}t und verschiedenen Korrelaten mithilfe validierter Messinstrumente untersucht. In vorliegender Arbeit wurden die Daten der im Studienzentrum W{\"u}rzburg rekrutierten Patienten ausgewertet. Eine Stichprobe von 770 Krebspatienten wurde ambulant (25,7\%), station{\"a}r (43,4\%) und in der Rehabilitation (30,9\%) rekrutiert. Alle Patienten waren zwischen 18 und 75 Jahre alt, 52,9\% waren weiblich. Das Durchschnittsalter der Befragten lag bei 57,2 Jahren. Die h{\"a}ufigsten Tumorlokalisationen waren die der Brustdr{\"u}se (26,4\%), der Verdauungsorgane (26,7\%) und die der m{\"a}nnlichen Genitalorgane (10,0\%). Suizidalit{\"a}t wurde bestimmt, indem das Item 9 aus dem PHQ-9„Gedanken, dass Sie lieber tot w{\"a}ren oder sich Leid zuf{\"u}gen m{\"o}chten" mit den Antwortm{\"o}glichkeiten „{\"u}berhaupt nicht", „an einzelnen Tagen", „an der H{\"a}lfte der Tage" oder „an beinahe jedem Tag" verwendet wurde. In vorliegender Arbeit wurde ein Patient als suizidal eingestuft, wenn er im PHQ-9 bei Item 9 zur Suizidalit{\"a}t 1= „an einzelnen Tagen", 2= „an der H{\"a}lfte der Tage" oder 3= „an beinahe jedem Tag" angegeben hat. Die Pr{\"a}valenzrate von Suizidalit{\"a}t bei Krebspatienten liegt bei 14,2\%. Die Faktoren Distress, Inanspruchnahme psychosozialer Unterst{\"u}tzung und Depressivit{\"a}t besitzen f{\"u}r Suizidalit{\"a}t eine unabh{\"a}ngige Vorhersagekraft. Ein univariater Zusammenhang mit Suizidalit{\"a}t wird f{\"u}r die Faktoren Geschlecht, Angst, Schmerz und Karnofsky-Status (k{\"o}rperliche Funktionsf{\"a}higkeit) festgestellt. Einer Adjustierung f{\"u}r andere Risikofaktoren h{\"a}lt dieser jedoch nicht stand. Die Faktoren Alter, Stigmatisierungspotential von Tumoren und negative Prognose von Tumoren h{\"a}ngen univariat nicht signifikant mit Suizidalit{\"a}t zusammen. Schlussfolgerung dieser Arbeit ist, dass auf m{\"o}gliche Suizidalit{\"a}t bei Krebspatienten im Klinikalltag besonders geachtet werden muss und weitere Studien zur validen Erfassung von Suizidalit{\"a}t notwendig sind.}, subject = {Suizidalit{\"a}t}, language = {de} } @article{WagnerAshbyKurtzetal.2015, author = {Wagner, Martin and Ashby, Damien R. and Kurtz, Caroline and Alam, Ahsan and Busbridge, Mark and Raff, Ulrike and Zimmermann, Josef and Heuschmann, Peter U. and Wanner, Christoph and Schramm, Lothar}, title = {Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease}, series = {PLoS One}, volume = {10}, journal = {PLoS One}, number = {4}, doi = {10.1371/journal.pone.0123072}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-125514}, pages = {e0123072}, year = {2015}, abstract = {Background Anemia is common and is associated with impaired clinical outcomes in diabetic chronic kidney disease (CKD). It may be explained by reduced erythropoietin (EPO) synthesis, but recent data suggest that EPO-resistance and diminished iron availability due to inflammation contribute significantly. In this cohort study, we evaluated the impact of hepcidin-25—the key hormone of iron-metabolism—on clinical outcomes in diabetic patients with CKD along with endogenous EPO levels. Methods 249 diabetic patients with CKD of any stage, excluding end-stage renal disease (ESRD), were enrolled (2003-2005), if they were not on EPO-stimulating agent and iron therapy. Hepcidin-25 levels were measured by radioimmunoassay. The association of hepcidin-25 at baseline with clinical variables was investigated using linear regression models. All-cause mortality and a composite endpoint of CKD progression (ESRD or doubling of serum creatinine) were analyzed by Cox proportional hazards models. Results Patients (age 67 yrs, 53\% male, GFR 51 ml/min, hemoglobin 131 g/L, EPO 13.5 U/L, hepcidin-25 62.0 ng/ml) were followed for a median time of 4.2 yrs. Forty-nine patients died (19.7\%) and forty (16.1\%) patients reached the composite endpoint. Elevated hepcidin levels were independently associated with higher ferritin-levels, lower EPO-levels and impaired kidney function (all p<0.05). Hepcidin was related to mortality, along with its interaction with EPO, older age, greater proteinuria and elevated CRP (all p<0.05). Hepcidin was also predictive for progression of CKD, aside from baseline GFR, proteinuria, low albumin- and hemoglobin-levels and a history of CVD (all p<0.05). Conclusions We found hepcidin-25 to be associated with EPO and impaired kidney function in diabetic CKD. Elevated hepcidin-25 and EPO-levels were independent predictors of mortality, while hepcidin-25 was also predictive for progression of CKD. Both hepcidin-25 and EPO may represent important prognostic factors of clinical outcome and have the potential to further define "high risk" populations in CKD.}, language = {en} } @article{LukasczikGerlichSchuleretal.2015, author = {Lukasczik, Matthias and Gerlich, Christian and Schuler, Michael and Neuderth, Silke and Dlugosch, Gabriele and Faller, Hermann}, title = {Stress and resources in women attending an inpatient prevention/rehabilitation measure for parents: Secondary analysis of quality assurance data}, series = {Open Journal of Medical Psychology}, volume = {4}, journal = {Open Journal of Medical Psychology}, doi = {10.4236/ojmp.2015.42003}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-125316}, pages = {23-34}, year = {2015}, abstract = {Questionnaire data from two projects on the development of quality assurance instruments for an inpatient rehabilitation/prevention program for parents were used for a secondary analysis. In this analysis, the associations of gains in a psychosocial resource (parenting self-efficacy) and two types of stressors experienced by mothers at the start of treatment (parenting hassles, depressive symptoms) with general life satisfaction and satisfaction with health at the end of treatment were explored. Structural equation modeling was applied to data from N = 1724 female patients. Potential resource-stressor interactions were tested using the Latent Moderated Structural Equations approach. Results showed that parenting hassles were negatively associated with general life satisfaction and satisfaction with health while self-efficacy gains were weakly positively correlated with both variables. No interaction of parenting hassles and self-efficacy gains was found. Depressive symptoms were negatively associated with both satisfaction measures. In these models, self-efficacy gains were not substantially correlated with life satisfaction, but showed a small association with satisfaction with health. There was no significant interaction of depressive symptoms and self-efficacy gains. The findings imply that interventions for distressed mothers—as exemplarily illustrated by this inpatient setting—should focus on identifying and reducing initial stressors as these may continue to impair mothers' subjective health despite gains in parenting-related resources.}, language = {en} } @article{HohmannMillesSchinkeetal.2014, author = {Hohmann, Christopher and Milles, Bianca and Schinke, Michael and Schroeter, Michael and Ulzheimer, Jochen and Kraft, Peter and Kleinschnitz, Christoph and Lehmann, Paul V. and Kuerten, Stefanie}, title = {Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood}, series = {Acta Neuropathologica Communications}, volume = {2}, journal = {Acta Neuropathologica Communications}, number = {138}, issn = {2051-5960}, doi = {10.1186/s40478-014-0138-2}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-120580}, year = {2014}, abstract = {INTRODUCTION: B cells are attracting increasing attention in the pathogenesis of multiple sclerosis (MS). B cell-targeted therapies with monoclonal antibodies or plasmapheresis have been shown to be successful in a subset of patients. Here, patients with either relapsing-remitting (n = 24) or secondary progressive (n = 6) MS presenting with an acute clinical relapse were screened for their B cell reactivity to brain antigens and were re-tested three to nine months later. Enzyme-linked immunospot technique (ELISPOT) was used to identify brain-reactive B cells in peripheral blood mononuclear cells (PBMC) directly ex vivo and after 96 h of polyclonal stimulation. Clinical severity of symptoms was determined using the Expanded Disability Status Scale (EDSS). RESULTS: Nine patients displayed B cells in the blood producing brain-specific antibodies directly ex vivo. Six patients were classified as B cell positive donors only after polyclonal B cell stimulation. In 15 patients a B cell response to brain antigens was absent. Based on the autoreactive B cell response we categorized MS relapses into three different patterns. Patients who displayed brain-reactive B cell responses both directly ex vivo and after polyclonal stimulation (pattern I) were significantly younger than patients in whom only memory B cell responses were detectable or entirely absent (patterns II and III; p = 0.003). In one patient a conversion to a positive B cell response as measured directly ex vivo and subsequently also after polyclonal stimulation was associated with the development of a clinical relapse. The evaluation of the predictive value of a brain antigen-specific B cell response showed that seven of eight patients (87.5\%) with a pattern I response encountered a clinical relapse during the observation period of 10 months, compared to two of five patients (40\%) with a pattern II and three of 14 patients (21.4\%) with a pattern III response (p = 0.0005; hazard ratio 6.08 (95\% confidence interval 1.87-19.77). CONCLUSIONS: Our data indicate actively ongoing B cell-mediated immunity against brain antigens in a subset of MS patients that may be causative of clinical relapses and provide new diagnostic and therapeutic options for a subset of patients.}, language = {en} } @article{KraftDrechslerGunrebenetal.2014, author = {Kraft, Peter and Drechsler, Christiane and Gunreben, Ignaz and Nieswandt, Bernhard and Stoll, Guido and Heuschmann, Peter Ulrich and Kleinschnitz, Christoph}, title = {Von Willebrand Factor Regulation in Patients with Acute and Chronic Cerebrovascular Disease: A Pilot, Case-Control Study}, series = {PLoS ONE}, volume = {9}, journal = {PLoS ONE}, number = {6}, issn = {1932-6203}, doi = {10.1371/journal.pone.0099851}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-119588}, pages = {e99851}, year = {2014}, abstract = {Background and Purpose In animal models, von Willebrand factor (VWF) is involved in thrombus formation and propagation of ischemic stroke. However, the pathophysiological relevance of this molecule in humans, and its potential use as a biomarker for the risk and severity of ischemic stroke remains unclear. This study had two aims: to identify predictors of altered VWF levels and to examine whether VWF levels differ between acute cerebrovascular events and chronic cerebrovascular disease (CCD). Methods A case-control study was undertaken between 2010 and 2013 at our University clinic. In total, 116 patients with acute ischemic stroke (AIS) or transitory ischemic attack (TIA), 117 patients with CCD, and 104 healthy volunteers (HV) were included. Blood was taken at days 0, 1, and 3 in patients with AIS or TIA, and once in CCD patients and HV. VWF serum levels were measured and correlated with demographic and clinical parameters by multivariate linear regression and ANOVA. Results Patients with CCD (158±46\%) had significantly higher VWF levels than HV (113±36\%, P<0.001), but lower levels than AIS/TIA patients (200±95\%, P<0.001). Age, sex, and stroke severity influenced VWF levels (P<0.05). Conclusions VWF levels differed across disease subtypes and patient characteristics. Our study confirms increased VWF levels as a risk factor for cerebrovascular disease and, moreover, suggests that it may represent a potential biomarker for stroke severity, warranting further investigation.}, language = {en} } @phdthesis{Carl2020, author = {Carl, Corinna}, title = {Vergleichende Bestimmung des dentalen Alters von Kindern und Jugendlichen mit Hilfe des "London Atlas of Dental Development", der Score-Methode nach Demirjian sowie ihrer Modifikation nach Willems}, doi = {10.25972/OPUS-21536}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-215362}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2020}, abstract = {Es wurde anhand von 500 OPGs aus der kieferorthop{\"a}dischen Abteilung des Universit{\"a}tsklinikums W{\"u}rzburg eine dentale Altersbestimmung mit Hilfe des London Atlas of Dental Development, der Methode nach Demirjian sowie ihrer Modifikation nach Willems durchgef{\"u}hrt. Ziel war es herauszufinden, ob zuverl{\"a}ssig vom dentalen auf das chronologische Alter geschlossen werden kann. Die Methode nach Willems (M= -0,33J, SD=1,06J) ist der Methode nach Demirjian (M=-0,08J SD= 1,27J) und dem London Atlas (M=0,34J SD=1,09J) {\"u}berlegen und kann auf die deutsche Population angewendet werden.}, subject = {Altersbestimmung}, language = {de} } @phdthesis{MartingebZiegler2021, author = {Martin [geb. Ziegler], Eva Dorothea}, title = {Komorbidit{\"a}ten bei Patienten mit Bull{\"o}sem Pemphigoid}, doi = {10.25972/OPUS-24159}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-241595}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2021}, abstract = {Das Bull{\"o}se Pemphigoid (BP) ist eine blasenbildende Autoimmunerkrankung der Haut, die durch subepidermale Blasenbildung und Antik{\"o}rper (AK) gegen bestimmte hemidesmosomale Proteine der Basalmembran (BM) charakterisiert ist. Zielantigene sind BP180 und BP230. Im Fokus dieser Arbeit stand die retrospektive Identifikation und Datenerhebung von Patienten mit BP, die in der Dermatologie der Uniklinik W{\"u}rzburg behandelt wurden. Zudem wurde eine Kontrollgruppe aus Patienten mit Basalzellkarzinom etabliert. Es konnten (hoch-)signifikante Assoziationen zwischen dem BP und verschiedenen Laborparametern (u.a. Leukozytose, Eosinophilie, Thrombozytose, An{\"a}mie, Kreatinin erh{\"o}ht) sowie Erkrankungen (u.a. neurologische Erkrankungen (Schlaganfall, Demenz, MP, MS und Epilepsie) sowie psychiatrischen Erkrankungen (HOPS, Depression) und Diabetes mellitus) nachgewiesen werden.}, subject = {Bull{\"o}ses Pemphigoid}, language = {de} } @article{DrechslerRitzTomaschitzetal.2013, author = {Drechsler, Christiane and Ritz, Eberhard and Tomaschitz, Andreas and Pilz, Stefan and Sch{\"o}nfeld, Stephan and Blouin, Katja and Bidlingmaier, Martin and Hammer, Fabian and Krane, Vera and M{\"a}rz, Winfried and Allolio, Bruno and Fassnacht, Martin and Wanner, Christoph}, title = {Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients}, series = {European Heart Journal}, volume = {34}, journal = {European Heart Journal}, doi = {10.1093/eurheartj/ehs361}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-132562}, pages = {578-585}, year = {2013}, abstract = {Background: Sudden cardiac death is common and accounts largely for the excess mortality of patients on maintenance dialysis. It is unknown whether aldosterone and cortisol increase the incidence of sudden cardiac death in dialysis patients. Methods and results: We analysed data from 1255 diabetic haemodialysis patients participating in the German Diabetes and Dialysis Study (4D Study). Categories of aldosterone and cortisol were determined at baseline and patients were followed for a median of 4 years. By Cox regression analyses, hazard ratios (HRs) were determined for the effect of aldosterone, cortisol, and their combination on sudden death and other adjudicated cardiovascular outcomes. The mean age of the patients was 66 ± 8 years (54\% male). Median aldosterone was <15 pg/mL (detection limit) and cortisol 16.8 µg/dL. Patients with aldosterone levels >200 pg/mL had a significantly higher risk of sudden death (HR: 1.69; 95\% CI: 1.06-2.69) compared with those with an aldosterone <15 pg/mL. The combined presence of high aldosterone (>200 pg/mL) and high cortisol (>21.1 µg/dL) levels increased the risk of sudden death in striking contrast to patients with low aldosterone (<15 pg/mL) and low cortisol (<13.2 µg/dL) levels (HR: 2.86, 95\% CI: 1.32-6.21). Furthermore, all-cause mortality was significantly increased in the patients with high levels of both hormones (HR: 1.62, 95\% CI: 1.01-2.62). Conclusions: The joint presence of high aldosterone and high cortisol levels is strongly associated with sudden cardiac death as well as all-cause mortality in haemodialysed type 2 diabetic patients. Whether a blockade of the mineralocorticoid receptor decreases the risk of sudden death in these patients must be examined in future trials.}, language = {en} } @article{MarenholzEsparzaGordilloRueschendorfetal.2015, author = {Marenholz, Ingo and Esparza-Gordillo, Jorge and R{\"u}schendorf, Franz and Bauerfeind, Anja and Strachan, David P. and Spycher, Ben D. and Baurecht, Hansj{\"o}rg and Magaritte-Jeannin, Patricia and S{\"a}{\"a}f, Annika and Kerkhof, Marjan and Ege, Markus and Baltic, Svetlana and Matheson, Melanie C. and Li, Jin and Michel, Sven and Ang, Wei Q. and McArdle, Wendy and Arnold, Andreas and Homuth, Georg and Demenais, Florence and Bouzigon, Emmanuelle and S{\"o}derh{\"a}ll, Cilla and Pershagen, G{\"o}ran and de Jongste, Johan C. and Postma, Dirkje S. and Braun-Fahrl{\"a}nder, Charlotte and Horak, Elisabeth and Ogorodova, Ludmila M. and Puzyrev, Valery P. and Bragina, Elena Yu and Hudson, Thomas J. and Morin, Charles and Duffy, David L. and Marks, Guy B. and Robertson, Colin F. and Montgomery, Grant W. and Musk, Bill and Thompson, Philip J. and Martin, Nicholas G. and James, Alan and Sleiman, Patrick and Toskala, Elina and Rodriguez, Elke and F{\"o}lster-Holst, Regina and Franke, Andre and Lieb, Wolfgang and Gieger, Christian and Heinzmann, Andrea and Rietschel, Ernst and Keil, Thomas and Cichon, Sven and N{\"o}then, Markus M. and Pennel, Craig E. and Sly, Peter D. and Schmidt, Carsten O. and Matanovic, Anja and Schneider, Valentin and Heinig, Matthias and H{\"u}bner, Norbert and Holt, Patrick G. and Lau, Susanne and Kabesch, Michael and Weidinger, Stefan and Hakonarson, Hakon and Ferreira, Manuel A. R. and Laprise, Catherine and Freidin, Maxim B. and Genuneit, Jon and Koppelman, Gerard H. and Mel{\´e}n, Erik and Dizier, Marie-H{\´e}l{\`e}ne and Henderson, A. John and Lee, Young Ae}, title = {Meta-analysis identifies seven susceptibility loci involved in the atopic march}, series = {Nature Communications}, volume = {6}, journal = {Nature Communications}, number = {8804}, doi = {10.1038/ncomms9804}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-139835}, year = {2015}, abstract = {Eczema often precedes the development of asthma in a disease course called the 'atopic march'. To unravel the genes underlying this characteristic pattern of allergic disease, we conduct a multi-stage genome-wide association study on infantile eczema followed by childhood asthma in 12 populations including 2,428 cases and 17,034 controls. Here we report two novel loci specific for the combined eczema plus asthma phenotype, which are associated with allergic disease for the first time; rs9357733 located in EFHC1 on chromosome 6p12.3 (OR 1.27; P = 2.1 x 10(-8)) and rs993226 between TMTC2 and SLC6A15 on chromosome 12q21.3 (OR 1.58; P = 5.3 x 10(-9)). Additional susceptibility loci identified at genome-wide significance are FLG (1q21.3), IL4/KIF3A (5q31.1), AP5B1/OVOL1 (11q13.1), C11orf30/LRRC32 (11q13.5) and IKZF3 (17q21). We show that predominantly eczema loci increase the risk for the atopic march. Our findings suggest that eczema may play an important role in the development of asthma after eczema.}, language = {en} } @article{HaeuslerHermKunzeetal.2012, author = {Haeusler, Karl Georg and Herm, Juliane and Kunze, Claudia and Kr{\"u}ll, Matthias and Brechtel, Lars and Lock, J{\"u}rgen and Hohenhaus, Marc and Heuschmann, Peter U. and Fiebach, Jochen B. and Haverkamp, Wilhelm and Endres, Matthias and Jungehulsing, Gerhard Jan}, title = {Rate of cardiac arrhythmias and silent brain lesions in experienced marathon runners: rationale, design and baseline data of the Berlin Beat of Running study}, series = {BMC Cardiovascular Disorders}, volume = {12}, journal = {BMC Cardiovascular Disorders}, number = {69}, doi = {10.1186/1471-2261-12-69}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-133677}, year = {2012}, abstract = {Background: Regular exercise is beneficial for cardiovascular health but a recent meta-analysis indicated a relationship between extensive endurance sport and a higher risk of atrial fibrillation, an independent risk factor for stroke. However, data on the frequency of cardiac arrhythmias or (clinically silent) brain lesions during and after marathon running are missing. Methods/Design: In the prospective observational "Berlin Beat of Running" study experienced endurance athletes underwent clinical examination (CE), 3 Tesla brain magnetic resonance imaging (MRI), carotid ultrasound imaging (CUI) and serial blood sampling (BS) within 2-3 days prior (CE, MRI, CUI, BS), directly after (CE, BS) and within 2 days after (CE, MRI, BS) the 38\(^{th}\) BMW BERLIN-MARATHON 2011. All participants wore a portable electrocardiogram (ECG)-recorder throughout the 4 to 5 days baseline study period. Participants with pathological MRI findings after the marathon, troponin elevations or detected cardiac arrhythmias will be asked to undergo cardiac MRI to rule out structural abnormalities. A follow-up is scheduled after one year. Results: Here we report the baseline data of the enrolled 110 athletes aged 36-61 years. Their mean age was 48.8 \(\pm\) 6.0 years, 24.5\% were female, 8.2\% had hypertension and 2.7\% had hyperlipidaemia. Participants have attended a mean of 7.5 \(\pm\) 6.6 marathon races within the last 5 years and a mean of 16 \(\pm\) 36 marathon races in total. Their weekly running distance prior to the 38\(^{th}\) BMW BERLIN-MARATHON was 65 \(\pm\) 17 km. Finally, 108 (98.2\%) Berlin Beat-Study participants successfully completed the 38\(^{th}\) BMW BERLIN-MARATHON 2011. Discussion: Findings from the "Berlin Beats of Running" study will help to balance the benefits and risks of extensive endurance sport. ECG-recording during the marathon might contribute to identify athletes at risk for cardiovascular events. MRI results will give new insights into the link between physical stress and brain damage.}, language = {en} } @article{DrechslerSchmiedekeNiemannetal.2013, author = {Drechsler, Christiane and Schmiedeke, Benjamin and Niemann, Markus and Schmiedeke, Daniel and Kr{\"a}mer, Johannes and Turkin, Irina and Blouin, Katja and Emmert, Andrea and Pilz, Stefan and Obermayer-Pietsch, Barbara and Wiedemann, Frank and Breunig, Frank and Wanner, Christoph}, title = {Potential role of vitamin D deficiency on Fabry cardiomyopathy}, series = {Journal of Inherited Metabolic Disease}, volume = {37}, journal = {Journal of Inherited Metabolic Disease}, number = {2}, doi = {10.1007/s10545-013-9653-8}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-132102}, pages = {289-295}, year = {2013}, abstract = {Patients with Fabry disease frequently develop left ventricular (LV) hypertrophy and renal fibrosis. Due to heat intolerance and an inability to sweat, patients tend to avoid exposure to sunlight. We hypothesized that subsequent vitamin D deficiency may contribute to Fabry cardiomyopathy. This study investigated the vitamin D status and its association with LV mass and adverse clinical symptoms in patients with Fabry disease. 25-hydroxyvitamin D (25[OH]D) was measured in 111 patients who were genetically proven to have Fabry disease. LV mass and cardiomyopathy were assessed by magnetic resonance imaging and echocardiography. In cross-sectional analyses, associations with adverse clinical outcomes were determined by linear and binary logistic regression analyses, respectively, and were adjusted for age, sex, BMI and season. Patients had a mean age of 40 ± 13 years (42 \% males), and a mean 25(OH)D of 23.5 ± 11.4 ng/ml. Those with overt vitamin D deficiency (25[OH]D ≤ 15 ng/ml) had an adjusted six fold higher risk of cardiomyopathy, compared to those with sufficient 25(OH)D levels >30 ng/ml (p = 0.04). The mean LV mass was distinctively different with 170 ± 75 g in deficient, 154 ± 60 g in moderately deficient and 128 ± 58 g in vitamin D sufficient patients (p = 0.01). With increasing severity of vitamin D deficiency, the median levels of proteinuria increased, as well as the prevalences of depression, edema, cornea verticillata and the need for medical pain therapy. In conclusion, vitamin D deficiency was strongly associated with cardiomyopathy and adverse clinical symptoms in patients with Fabry disease. Whether vitamin D supplementation improves complications of Fabry disease, requires a randomized controlled trial.}, language = {en} } @article{NeugebauerHeuschmannJuettler2012, author = {Neugebauer, Hermann and Heuschmann, Peter U. and J{\"u}ttler, Eric}, title = {DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry (DESTINY-R): design and protocols}, series = {BMC Neurology}, volume = {12}, journal = {BMC Neurology}, number = {115}, doi = {10.1186/1471-2377-12-115}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-133892}, year = {2012}, abstract = {Background: Randomized controlled trials (RCT) on the treatment of severe space-occupying infarction of the middle cerebral artery (malignant MCA infarction) showed that early decompressive hemicraniectomy (DHC) is life saving and improves outcome without promoting most severe disablity in patients aged 18-60 years. It is, however, unknown whether the results obtained in the randomized trials are reproducible in a broader population in and apart from an academical setting and whether hemicraniectomy has been implemented in clinical practice as recommended by national and international guidelines. In addition, they were not powered to answer further relevant questions, e. g. concerning the selection of patients eligible for and the timing of hemicraniectomy. Other important issues such as the acceptance of disability following hemicraniectomy, the existence of specific prognostic factors, the value of conservative therapeutic measures, and the overall complication rate related to hemicraniectomy have not been sufficiently studied yet. Methods/Design: DESTINY-R is a prospective, multicenter, open, controlled registry including a 12 months follow-up. The only inclusion criteria is unilateral ischemic MCA stroke affecting more than 50\% of the MCA-territory. The primary study hypothesis is to confirm the results of the RCT (76\% mRS <= 4 after 12 months) in the subgroup of patients additionally fulfilling the inclusion cirteria of the RCT in daily routine. Assuming a calculated proportion of 0.76 for successes and a sample size of 300 for this subgroup, the width of the 95\% CI, calculated using Wilson's method, will be 0.096 with the lower bound 0.709 and the upper bound 0.805. Discussion: The results of this study will provide information about the effectiveness of DHC in malignant MCA infarction in a broad population and a real-life situation in addition to and beyond RCT. Further prospectively obtained data will give crucial information on open questions and will be helpful in the plannig of upcomming treatment studies.}, language = {en} } @article{PruggerHeidrichWellmannetal.2012, author = {Prugger, Christof and Heidrich, Jan and Wellmann, J{\"u}rgen and Dittrich, Ralf and Brand, Stefan-Martin and Telgmann, Ralph and Breithardt, G{\"u}nter and Reinecke, Holger and Scheld, Hans and Kleine-Katth{\"o}fer, Peter and Heuschmann, Peter U. and Keil, Ulrich}, title = {Trends in Cardiovascular Risk Factors Among Patients With Coronary Heart Disease : Results From the EUROASPIRE I, II, and III Surveys in the M{\"u}nster Region}, series = {Deutsches {\"A}rzteblatt International}, volume = {109}, journal = {Deutsches {\"A}rzteblatt International}, number = {17}, doi = {10.3238/arztebl.2012.0303}, pages = {303-U21}, year = {2012}, abstract = {Background: Target values for cardiovascular risk factors in patients with coronary heart disease (CHD) are stated in guidelines for the prevention of cardiovascular disease. We studied secular trends in risk factors over a 12-year period among CHD patients in the region of Munster, Germany. Methods: The cross-sectional EUROASPIRE I, II and III surveys were performed in multiple centers across Europe. For all three, the Munster region was the participating German region. In the three periods 1995/96, 1999/2000, and 2006/07, the surveys included (respectively) 392, 402 and 457 <= 70-year-old patients with CHD in Munster who had sustained a coronary event at least 6 months earlier. Results: The prevalence of smoking remained unchanged, with 16.8\% in EUROASPIRE I and II and 18.4\% in EUROASPIRE III (p=0.898). On the other hand, high blood pressure and high cholesterol both became less common across the three EUROASPIRE studies (60.7\% to 69.4\% to 55.3\%, and 94.3\% to 83.4\% to 48.1\%, respectively; p<0.001 for both). Obesity became more common (23.0\% to 30.6\% to 43.1\%, p<0.001), as did treatment with antihypertensive and lipid-lowering drugs (80.4\% to 88.6\% to 94.3\%, and 35.0\% to 67.4\% to 87.0\%, respectively; p<0.001 for both). Conclusion: The observed trends in cardiovascular risk factors under-score the vital need for better preventive strategies in patients with CHD.}, language = {en} } @article{LeistnerBenikLaumeieretal.2012, author = {Leistner, Stefanie and Benik, Steffen and Laumeier, Inga and Ziegler, Annerose and Nieweler, Gabriele and Nolte, Christian H. and Heuschmann, Peter U. and Audebert, Heinrich J.}, title = {Secondary Prevention after Minor Stroke and TIA - Usual Care and Development of a Support Program}, series = {PLoS One}, volume = {7}, journal = {PLoS One}, number = {12}, doi = {10.1371/journal.pone.0049985}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-135247}, pages = {e49985}, year = {2012}, abstract = {Background: Effective methods of secondary prevention after stroke or TIA are available but adherence to recommended evidence-based treatments is often poor. The study aimed to determine the quality of secondary prevention in usual care and to develop a stepwise modeled support program. Methods: Two consecutive cohorts of patients with acute minor stroke or TIA undergoing usual outpatient care versus a secondary prevention program were compared. Risk factor control and medication adherence were assessed in 6-month follow-ups (6M-FU). Usual care consisted of detailed information concerning vascular risk factor targets given at discharge and regular outpatient care by primary care physicians. The stepwise modeled support program additionally employed up to four outpatient appointments. A combination of educational and behavioral strategies was employed. Results: 168 patients in the observational cohort who stated their openness to participate in a prevention program (mean age 64.7 y, admission blood pressure (BP): 155/84 mmHg) and 173 patients participating in the support program (mean age 67.6 y, BP: 161/84 mmHg) were assessed at 6 months. Proportions of patients with BP according to guidelines were 50\% in usual-care and 77\% in the support program (p<0.01). LDL<100 mg/dl was measured in 62 versus 71\% (p = 0.12). Proportions of patients who stopped smoking were 50 versus 79\% (p<0.01). 72 versus 89\% of patients with atrial fibrillation were on oral anticoagulation (p = 0.09). Conclusions: Risk factor control remains unsatisfactory in usual care. Targets of secondary prevention were met more often within the supported cohort. Effects on (cerebro-)vascular recurrence rates are going to be assessed in a multicenter randomized trial.}, language = {en} } @article{OcakDrechslerVossenetal.2014, author = {Ocak, Gurbey and Drechsler, Christiane and Vossen, Carla Y. and Vos, Hans L. and Rosendaal, Frits R. and Reitsma, Pieter H. and Hoffmann, Michael M. and M{\"a}rz, Winfried and Ouwehand, Willem H. and Krediet, Raymond T. and Boeschoten, Elisabeth W. and Dekker, Frido W. and Wanner, Christoph and Verduijn, Marion}, title = {Single Nucleotide Variants in the Protein C Pathway and Mortality in Dialysis Patients}, series = {PLOS ONE}, volume = {9}, journal = {PLOS ONE}, number = {5}, issn = {1932-6203}, doi = {10.1371/journal.pone.0097251}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-116265}, pages = {e97251}, year = {2014}, abstract = {Background: The protein C pathway plays an important role in the maintenance of endothelial barrier function and in the inflammatory and coagulant processes that are characteristic of patients on dialysis. We investigated whether common single nucleotide variants (SNV) in genes encoding protein C pathway components were associated with all-cause 5 years mortality risk in dialysis patients. Methods: Single nucleotides variants in the factor V gene (F5 rs6025; factor V Leiden), the thrombomodulin gene (THBD rs1042580), the protein C gene (PROC rs1799808 and 1799809) and the endothelial protein C receptor gene (PROCR rs867186, rs2069951, and rs2069952) were genotyped in 1070 dialysis patients from the NEtherlands COoperative Study on the Adequacy of Dialysis (NECOSAD) cohort) and in 1243 dialysis patients from the German 4D cohort. Results: Factor V Leiden was associated with a 1.5-fold (95\% CI 1.1-1.9) increased 5-year all-cause mortality risk and carriers of the AG/GG genotypes of the PROC rs1799809 had a 1.2-fold (95\% CI 1.0-1.4) increased 5-year all-cause mortality risk. The other SNVs in THBD, PROC, and PROCR were not associated with 5-years mortality. Conclusion: Our study suggests that factor V Leiden and PROC rs1799809 contributes to an increased mortality risk in dialysis patients.}, language = {en} } @article{LueckerathLapaMalzahnetal.2014, author = {L{\"u}ckerath, Katharina and Lapa, Constantin and Malzahn, Uwe and Samnick, Samuel and Einsele, Herrmann and Buck, Andreas K. and Herrmann, Ken and Knop, Stefan}, title = {18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-113107}, year = {2014}, abstract = {The aim of this study was to investigate the prognostic value of 18F-fluoro-deoxyglucose positron emission tomography-computed tomography (18F-FDG-PET/CT) in 37 patients with a history of multiple myeloma (MM) and suspected or confirmed recurrence after stem cell transplantation (SCT). All patients had been heavily pre-treated. Time to progression (TTP) and overall survival (OS) were correlated to a number of different PET-derived as well as clinical parameters. Impact on patient management was assessed. Absence of FDG-avid MM foci was a positive prognostic factor for both TTP and OS (p<0.01). Presence of >10 focal lesions correlated with both TTP (p<0.01) and OS (p<0.05). Interestingly, presence of >10 lesions in the appendicular skeleton proved to have the strongest association with disease progression. Intensity of glucose uptake and presence of extramedullary disease were associated with shorter TTP (p=0.037 and p=0.049, respectively). Manifestations in soft tissue structures turned out to be a strong negative predictor for both, TTP and OS (p<0.01, respectively). PET resulted in a change of management in 30\% of patients. Our data underline the prognostic value of 18F-FDG-PET/CT in MM patients also in the setting of post-SCT relapse. PET/CT has a significant impact on patient management.}, language = {en} } @article{WiedmannHeuschmannHillmannetal.2014, author = {Wiedmann, Silke and Heuschmann, Peter U. and Hillmann, Steffi and Busse, Otto and Wiethoelter, Horst and Walter, Georg M. and Seidel, Guenter and Misselwitz, Bjoern and Janssen, Alfred and Berger, Klaus and Burmeister, Christoph and Matthias, Christine and Kolominsky-Rabas, Peter and Hermanek, Peter}, title = {The Quality of Acute Stroke Care-an Analysis of Evidence-Based Indicators in 260 000 Patients}, series = {Deutsches {\"A}rzteblatt International}, volume = {111}, journal = {Deutsches {\"A}rzteblatt International}, number = {45}, issn = {1866-0452}, doi = {10.3238/arztebl.2014.0759}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-114747}, pages = {759-765}, year = {2014}, abstract = {Background: Stroke patients should be cared for in accordance with evidence-based guidelines. The extent of implementation of guidelines for the acute care of stroke patients in Germany has been unclear to date. Methods: The regional quality assurance projects that cooperate in the framework of the German Stroke Registers Study Group (Arbeitsgemeinschaft Deutscher Schlaganfall-Register, ADSR) collected data on the care of stroke patients in 627 hospitals in 2012. The quality of the acute hospital care of patients with stroke or transient ischemic attack (TIA) was assessed on the basis of 15 standardized, evidence-based quality indicators and compared across the nine participating regional quality assurance projects. Results: Data were obtained on more than 260 000 patients nationwide. Intravenous thrombolysis was performed in 59.7\% of eligible ischemic stroke patients patients (range among participating projects, 49.7-63.6\%). Dysphagia screening was documented in 86.2\% (range, 74.8-93.1\%). For the following indicators, the defined targets were not reached for all of Germany: antiaggregation within 48 hours, 93.4\% (range, 86.6-96.4\%); anticoagulation for atrial fibrillation, 77.6\% (range, 72.4-80.1\%); standardized dysphagia screening, 86.2\% (range, 74.8-93.1\%); oral and written information of the patients or their relatives, 86.1\% (range, 75.4-91.5\%). The rate of patients examined or treated by a speech therapist was in the target range. Conclusion: The defined targets were reached for most of the quality indicators. Some indicators, however, varied widely across regional quality assurance projects. This implies that the standardization of care for stroke patients in Germany has not yet been fully achieved.}, language = {en} } @article{GrabenhenrichReichFischeretal.2014, author = {Grabenhenrich, Linus B. and Reich, Andreas and Fischer, Felix and Zepp, Fred and Forster, Johannes and Schuster, Antje and Bauer, Carl-Peter and Bergmann, Renate L. and Bergmann, Karl E. and Wahn, Ulrich and Keil, Thomas and Lau, Susanne}, title = {The Novel 10-Item Asthma Prediction Tool: External Validation in the German MAS Birth Cohort}, series = {PLOS ONE}, volume = {9}, journal = {PLOS ONE}, number = {12}, issn = {1932-6203}, doi = {10.1371/journal.pone.0115852}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-114202}, pages = {e115852}, year = {2014}, abstract = {Background: A novel non-invasive asthma prediction tool from the Leicester Cohort, UK, forecasts asthma at age 8 years based on 10 predictors assessed in early childhood, including current respiratory symptoms, eczema, and parental history of asthma. Objective: We aimed to externally validate the proposed asthma prediction method in a German birth cohort. Methods: The MAS-90 study (Multicentre Allergy Study) recorded details on allergic diseases prospectively in about yearly follow-up assessments up to age 20 years in a cohort of 1,314 children born 1990. We replicated the scoring method from the Leicester cohort and assessed prediction, performance and discrimination. The primary outcome was defined as the combination of parent-reported wheeze and asthma drugs (both in last 12 months) at age 8. Sensitivity analyses assessed model performance for outcomes related to asthma up to age 20 years. Results: For 140 children parents reported current wheeze or cough at age 3 years. Score distribution and frequencies of later asthma resembled the Leicester cohort: 9\% vs. 16\% (MAS-90 vs. Leicester) of children at low risk at 3 years had asthma at 8 years, at medium risk 45\% vs. 48\%. Performance of the asthma prediction tool in the MAS-90 cohort was similar (Brier score 0.22 vs. 0.23) and discrimination slightly better than in the original cohort (area under the curve, AUC 0.83 vs. 0.78). Prediction and discrimination were robust against changes of inclusion criteria, scoring and outcome definitions. The secondary outcome 'physicians' diagnosed asthma at 20 years' showed the highest discrimination (AUC 0.89). Conclusion: The novel asthma prediction tool from the Leicester cohort, UK, performed well in another population, a German birth cohort, supporting its use and further development as a simple aid to predict asthma risk in clinical settings.}, language = {en} } @article{BuderGesierichGelbrichetal.2013, author = {Buder, Kristina and Gesierich, Anja and Gelbrich, G{\"o}tz and Goebeler, Matthias}, title = {Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives}, series = {Cancer Medicine}, volume = {2}, journal = {Cancer Medicine}, number = {5}, doi = {10.1002/cam4.133}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-97175}, pages = {674-686}, year = {2013}, abstract = {Up to 50\% of patients with uveal melanoma develop metastatic disease with poor prognosis. Regional, mainly liver-directed, therapies may induce limited tumor responses but do not improve overall survival. Response rates of metastatic uveal melanoma (MUM) to systemic chemotherapy are poor. Insights into the molecular biology of MUM recently led to investigation of new drugs. In this study, to compare response rates of systemic treatment for MUM we searched Pubmed/Web of Knowledge databases and ASCO website (1980-2013) for "metastatic/uveal/melanoma" and "melanoma/eye." Forty studies (one case series, three phase I, five pilot, 22 nonrandomized, and two randomized phase II, one randomized phase III study, data of three expanded access programs, three retrospective studies) with 841 evaluable patients were included in the numeric outcome analysis. Complete or partial remissions were observed in 39/841 patients (overall response rate [ORR] 4.6\%; 95\% confidence intervals [CI] 3.3-6.3\%), no responses were observed in 22/40 studies. Progression-free survival ranged from 1.8 to 7.2, median overall survival from 5.2 to 19.0 months as reported in 21/40 and 26/40 studies, respectively. Best responses were seen for chemoimmunotherapy (ORR 10.3\%; 95\% CI 4.8-18.7\%) though mainly in first-line patients. Immunotherapy with ipilimumab, antiangiogenetic approaches, and kinase inhibitors have not yet proven to be superior to chemotherapy. MEK inhibitors are currently investigated in a phase II trial with promising preliminary data. Despite new insights into genetic and molecular background of MUM, satisfying systemic treatment approaches are currently lacking. Study results of innovative treatment strategies are urgently awaited.}, language = {en} } @article{KleinschnitzGoebelMeuthetal.2014, author = {Kleinschnitz, Christoph and G{\"o}bel, Kerstin and Meuth, Sven G. and Kraft, Peter}, title = {Glatiramer acetate does not protect from acute ischemic stroke in mice}, doi = {10.1186/2040-7378-6-4}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-110528}, year = {2014}, abstract = {Background The role of the immune system in the pathophysiology of acute ischemic stroke is increasingly recognized. However, targeted treatment strategies to modulate immunological pathways in stroke are still lacking. Glatiramer acetate is a multifaceted immunomodulator approved for the treatment of relapsing-remitting multiple sclerosis. Experimental studies suggest that glatiramer acetate might also work in other neuroinflammatory or neurodegenerative diseases apart from multiple sclerosis. Findings We evaluated the efficacy of glatiramer acetate in a mouse model of brain ischemia/reperfusion injury. 60 min of transient middle cerebral artery occlusion was induced in male C57Bl/6 mice. Pretreatment with glatiramer acetate (3.5 mg/kg bodyweight) 30 min before the induction of stroke did not reduce lesion volumes or improve functional outcome on day 1. Conclusions Glatiramer acetate failed to protect from acute ischemic stroke in our hands. Further studies are needed to assess the true therapeutic potential of glatiramer acetate and related immunomodulators in brain ischemia.}, language = {en} } @article{OezkurGorskiPeltzetal.2014, author = {Oezkur, Mehmet and Gorski, Armin and Peltz, Jennifer and Wagner, Martin and Lazariotou, Maria and Schimmer, Christoph and Heuschmann, Peter U. and Leyh, Rainer G.}, title = {Preoperative serum h-FABP concentration is associated with postoperative incidence of acute kidney injury in patients undergoing cardiac surgery}, doi = {10.1186/1471-2261-14-117}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-110480}, year = {2014}, abstract = {Background Fatty acid binding protein (FABP) is an intracellular transport protein associated with myocardial damage size in patients undergoing cardiac surgery. Furthermore, elevated FABP serum concentrations are related to a number of common comorbidities, such as heart failure, chronic kidney disease, diabetes mellitus, and metabolic syndrome, which represent important risk factors for postoperative acute kidney injury (AKI). Data are lacking on the association between preoperative FABP serum level and postoperative incidence of AKI. Methods This prospective cohort study investigated the association between preoperative h-FABP serum concentrations and postoperative incidence of AKI, hospitalization time and length of ICU treatment. Blood samples were collected according to a predefined schedule. The AKI Network definition of AKI was used as primary endpoint. All associations were analysed using descriptive and univariate analyses. Results Between 05/2009 and 09/2009, 70 patients undergoing cardiac surgery were investigated. AKI was observed in 45 patients (64\%). Preoperative median (IQR) h-FABP differed between the AKI group (2.9 [1.7-4.1] ng/ml) and patients without AKI (1.7 [1.1-3.3] ng/ml; p = 0.04), respectively. Patients with AKI were significantly older. No statistically significant differences were found for gender, type of surgery, operation duration, CPB-, or X-Clamp time, preoperative cardiac enzymes, HbA1c, or CRP between the two groups. Preoperative h-FABP was also correlated with the length of ICU stay (rs = 0.32, p = 0.007). Conclusions We found a correlation between preoperative serum h-FABP and the postoperative incidence of AKI. Our results suggest a potential role for h-FABP as a biomarker for AKI in cardiac surgery.}, language = {en} } @phdthesis{Ruecker2021, author = {R{\"u}cker, Viktoria}, title = {Time trends and determinants of stroke mortality in Germany}, doi = {10.25972/OPUS-23311}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-233116}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2021}, abstract = {In several countries, a decline in mortality, case-fatality and recurrence rates of stroke was observed. However, studies investigating sex-specific and subtype-specific (pathological and etiological) time trends in stroke mortality, case-fatality and recurrence rates are scarce, especially in Germany. The decline in ischemic stroke mortality and case-fatality might be associated with the high quality of acute care of ischemic stroke, but the exact determinants of early outcome remains unknown for Germany. Therefore, as first step of this thesis, we investigated the time trends of subtype- and sex-specific age- standardized stroke mortality rates in Germany from 1998 to 2015, by applying joinpoint regression on official causes of death statistics, provided by the Federal Statistical Office. Furthermore, a regional comparison of the time trends in stroke mortality between East and West was conducted. In the second step, time trends in case-fatality and stroke recurrence rates were analyzed using data from a population- based stroke register in Germany between 1996 and 2015. The analysis was stratified by sex and etiological subtype of ischemic stroke. In the third step, quality of stroke care and the association between adherence to measures of quality of acute ischemic stroke care and in-hospital mortality was estimated based on data from nine regional hospital-based stroke registers in Germany from the years 2015 and 2016. We showed that in Germany, age-standardized stroke mortality declined by over 50\% from 1998 to 2015 both, in women and men. Stratified by the pathological subtypes of stroke, the decrease in mortality was larger in ischemic stroke compared to hemorrhagic stroke. Different patterns in the time trends of stroke were observed for stroke subtypes, regions in Germany (former Eastern part of Germany (EG), former Western part of Germany (WG)) and sex, but in all strata a decline was found. By applying joinpoint regression, the number of changes in time trend differed between the regions and up to three changes in the trend in ischemic stroke mortality were detected. Trends in hemorrhagic stroke were in parallel between the regions with up to one change (in women) in joinpoint regression. Comparing the regions, stroke mortality was higher in EG compared to WG throughout the whole observed time period, however the differences between the regions started to diminish from 2007 onwards. Further it was found that, based on the population-based Erlangen Stroke Project (ESPro), case-fatality and recurrence rates in ischemic stroke patients are still high in Germany. 46\% died and 20\% got a recurrent stroke within the first five years after stroke. Case-fatality rates declined statistically significant from 1996 to 2015 across all ischemic stroke patients and all etiological subtypes of ischemic stroke. Based on Cox regression no statistically significant decrease in stroke recurrence was observed. Based on the pooled data of nine regional hospital-based stroke registers from the years 2015 and 2016 covering about 80\% of all hospitalized stroke patients in Germany, a high quality of care of acute ischemic stroke patients, measured via 11 evidence-based quality indicators (QI) of process of care, was observed. Across all registers, most QI reached the predefined target values for good quality of stroke care. 9 out of 11 QI showed a significant association with 7-day in-hospital mortality. An inverse linear association between overall adherence to QI and 7-day in-hospital mortality was observed. In conclusion, stroke mortality and case-fatality showed a favorable development over time in Germany, which might partly be due to improvements in acute treatment. This is supported by the association between overall adherence to quality of care and in-hospital mortality. However, there might be room for improvements in long-term secondary prevention, as no clear reduction in recurrence rates was observed.}, subject = {Schlaganfall}, language = {en} }